SCP Private Credit Income BDC 10-Q 8 Aug 23 2023 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2023	Aug. 04, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Amendment Flag	false
Document Period End Date	Jun. 30, 2023
Entity Registrant Name	SCP Private Credit Income BDC LLC
Entity Central Index Key	0001743415
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		25,190,253
Entity File Number	814-01294
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	500 Park Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10022
City Area Code	212
Local Phone Number	993-1670
Entity Interactive Data Current	Yes
Entity Tax Identification Number	83-0634992
Entity Ex Transition Period	false

Consolidated Statements of Asse

Consolidated Statements of Assets and Liabilities - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Investments at fair value:
Cash	$ 13,060	$ 16,697
Interest receivable	3,625	3,647
Receivable for investments sold	99	0
Prepaid expenses	86	22
Total assets	539,339	553,261
Liabilities
Distributions payable	0	10,825
Management fee payable (see note 3)	2,136	519
Incentive fee payable (see note 3)	2,039	4,025
Administration fee payable (see note 3)	105	108
Interest payable (see note 5)	4,731	4,041
Other liabilities and accrued expenses	617	940
Total liabilities	272,113	357,007
Commitments and contingencies (see note 6)
Unitholders' Capital
Common Unitholders' capital (25,190,253 and 18,992,563 units, respectively, issued and outstanding)	261,160	196,160
Accumulated distributable earnings	6,066	94
Total unitholders' capital	267,226	196,254
Total liabilities and unitholders' capital	$ 539,339	$ 553,261
Net asset value per unit	$ 10.61	$ 10.33
SPV Facility [Member]
Liabilities
Revolving credit facility	$ 235,800	$ 266,334
Subscription Facility [Member]
Liabilities
Revolving credit facility	26,685	70,215
Companies Less Than 5% Owned [Member]
Investments at fair value:
Investments at fair value	509,719	532,895
Companies 5% To 25% Owned [Member]
Investments at fair value:
Investments at fair value	$ 12,750	$ 0

Consolidated Statements of As_2

Consolidated Statements of Assets and Liabilities (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Common unit issued	25,190,253	18,992,563
Common unit outstanding	25,190,253	18,992,563
SPV Facility [Member]
Debt Instrument face amount	$ 236,500	$ 267,726
Net of unamortized debt issuance costs	700	1,392
Subscription Facility [Member]
Debt Instrument face amount	26,800	70,400
Net of unamortized debt issuance costs	115	185
Companies Less Than 5% Owned [Member]
Investments at cost	505,230	529,070
Companies 5% To 25% Owned [Member]
Investments at cost	$ 21,595	$ 0

Consolidated Statement of Opera

Consolidated Statement of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Investment Income:
Total investment income	$ 15,311	$ 9,618	$ 30,103	$ 18,265
Expenses:
Management fees (see note 3)	1,078	889	2,136	1,760
Incentive fees (see note 3)	1,582	736	1,054	1,586
Administration fees (see note 3)	105	93	210	181
Interest and other credit facility expenses (see note 5)	5,694	3,215	12,102	5,804
Other general and administrative expenses	256	246	522	451
Total expenses	8,715	5,179	16,024	9,782
Net investment income	6,596	4,439	14,079	8,483
Realized and unrealized gain (loss) on investments:
Net realized gain on companies less than 5% owned	74	0	74	0
Net change in unrealized gain (loss) on investments	2,291	(264)	(8,181)	507
Net realized and unrealized gain (loss) on investments	2,365	(264)	(8,107)	507
Net increase in unitholders' capital resulting from operations	$ 8,961	$ 4,175	$ 5,972	$ 8,990
Net Income Per Unit	$ 0.36	$ 0.24	$ 0.25	$ 0.52
Companies Less Than 5% Owned [Member]
Investment Income:
Interest:	$ 15,248	$ 9,573	$ 29,636	$ 18,095
Other income:	63	45	467	170
Realized and unrealized gain (loss) on investments:
Net realized gain on companies less than 5% owned	74	0	74	0
Net change in unrealized gain (loss) on investments	4,362	(264)	(6,110)	507
Companies 5% To 25% Owned [Member]
Realized and unrealized gain (loss) on investments:
Net change in unrealized gain (loss) on investments	$ (2,071)	$ 0	$ (2,071)	$ 0

Consolidated Statement of Chang

Consolidated Statement of Changes in Unitholders' Capital - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Increase (decrease) in unitholders' capital resulting from operations:
Net investment income	$ 6,596	$ 4,439	$ 14,079	$ 8,483
Net realized gain	74	0	74	0
Net change in unrealized gain (loss)	2,291	(264)	(8,181)	507
Net increase in unitholders' capital resulting from operations	8,961	4,175	5,972	8,990
Distributions to unitholders:
From net investment income	0	0	0	0
Increase in unitholders' capital resulting from capital activity:
Contributions	0	20,000	65,000	20,000
Net increase in unitholders' capital resulting from capital activity	0	20,000	65,000	20,000
Total increase in unitholders' capital	8,961	24,175	70,972	28,990
Unitholders' capital, beginning of period	258,265	180,928	196,254	176,113
Unitholders' capital, end of period	$ 267,226	$ 205,103	$ 267,226	$ 205,103
Units issued	0	1,855,288	6,197,690	1,855,288
Net increase from capital unit activity	0	1,855,288	6,197,690	1,855,288

Consolidated Statement of Cash

Consolidated Statement of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash Flows from Operating Activities:
Net increase in unitholders' capital resulting from operations	$ 5,972	$ 8,990
Adjustments to reconcile net increase in unitholders' capital resulting from operations to net cash provided by (used in) operating activities:
Net realized gain on investments	(74)	0
Net change in unrealized (gain) loss on investments	8,181	(507)
(Increase) decrease in operating assets:
Purchase of investments	(63,726)	(71,185)
Net accretion of discount on investments	(1,578)	(1,121)
Proceeds from disposition of investments	68,597	33,514
Capitalization of payment-in-kind income	(974)	(239)
Receivable for investments sold	(99)	(78)
Interest receivable	22	(376)
Prepaid expenses	(64)	(74)
Increase (decrease) in operating liabilities:
Management fee payable	1,617	1,760
Incentive fee payable	(1,986)	(739)
Administration fee payable	(3)	14
Interest payable	690	802
Other liabilities and accrued expenses	(323)	264
Deferred financing costs	794	838
Net Cash Provided by (Used in) Operating Activities	17,046	(28,137)
Cash Flows from Financing Activities:
Contributions from unitholders	65,000	20,000
Cash distributions paid	(10,825)	(7,277)
Proceeds from borrowings	35,168	72,500
Repayments of borrowings	(110,026)	(57,200)
Net Cash Provided by (Used in) Financing Activities	(20,683)	28,023
NET DECREASE IN CASH	(3,637)	(114)
CASH AT BEGINNING OF PERIOD	16,697	11,181
CASH AT END OF PERIOD	13,060	11,067
Supplemental disclosure of cash flow information:
Cash paid for interest	$ 11,412	$ 5,002

Consolidated Schedule of Invest

Consolidated Schedule of Investments - USD ($) $ in Thousands		6 Months Ended	12 Months Ended
		Jun. 30, 2023	Dec. 31, 2022
Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Cost		$ 520,487
Fair Value		514,531
Common Equity/Equity Interests/Warrants — 3.0%
Summary of Investment Holdings [Line Items]
Cost		6,338
Fair Value		7,938
Total Investments — 195.5%
Summary of Investment Holdings [Line Items]
Cost	[1]	526,825
Fair Value	[1]	522,469
Liabilities in Excess of Other Assets — (95.5%)
Summary of Investment Holdings [Line Items]
Fair Value		(255,243)
Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Cost			$ 528,920
Fair Value			532,753
Common Equity/Equity Interests/Warrants — 0.0%
Summary of Investment Holdings [Line Items]
Cost			150
Fair Value			142
Total Investments — 271.5%
Summary of Investment Holdings [Line Items]
Cost	[2]		529,070
Fair Value	[2]		532,895
Liabilities in Excess of Other Assets — (171.5%)
Summary of Investment Holdings [Line Items]
Fair Value			(336,641)
Net Assets — 100.0%
Summary of Investment Holdings [Line Items]
Fair Value		$ 267,226	$ 196,254
ACRES Commercial Mortgage, LLC | Diversified Financial Services | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Diversified Financial Services
Spread above Index	[3],[4]	S+705
Floor	[3]	1%
Interest Rate	[3],[5]	12.31%
Acquisition Date	[3]	Dec. 24, 2021
Maturity Date	[3]	Aug. 21, 2028
Par Amount	[3]	$ 12,660
Cost	[3]	12,453
Fair Value	[3]	$ 12,660
ACRES Commercial Mortgage, LLC | Diversified Financial Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Diversified Financial Services
Spread above Index	[3],[4]		S+705
Floor	[3]		1%
Interest Rate	[3],[6]		11.38%
Acquisition Date	[3]		Dec. 24, 2021
Maturity Date	[3]		Aug. 21, 2028
Par Amount	[3]		$ 12,660
Cost	[3]		12,437
Fair Value	[3]		$ 12,660
Alimera Sciences, Inc | Pharmaceuticals | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Pharmaceuticals
Spread above Index	[3],[4]	S+515
Floor	[3]	4.60%
Interest Rate	[3],[5]	10.32%
Acquisition Date	[3]	Dec. 31, 2019
Maturity Date	[3]	May 01, 2028
Par Amount	[3]	$ 5,893
Cost	[3]	5,905
Fair Value	[3]	$ 5,893
Alimera Sciences, Inc | Pharmaceuticals | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Pharmaceuticals
Spread above Index	[3],[4]		L+765
Floor	[3]		1.78%
Interest Rate	[3],[6]		11.82%
Acquisition Date	[3]		Dec. 31, 2019
Maturity Date	[3]		Jul. 01, 2024
Par Amount	[3]		$ 3,929
Cost	[3]		4,059
Fair Value	[3]		$ 4,145
All State Ag Parts, LLC | Trading Companies & Distributors | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Trading Companies & Distributors
Spread above Index	[3],[4]	S+575
Floor	[3]	1%
Interest Rate	[3],[5]	11.25%
Acquisition Date	[3]	Sep. 01, 2021
Maturity Date	[3]	Sep. 01, 2026
Par Amount	[3]	$ 5,191
Cost	[3]	5,124
Fair Value	[3]	$ 5,191
All State Ag Parts, LLC | Trading Companies & Distributors | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Trading Companies & Distributors
Spread above Index	[3],[4]		S+575
Floor	[3]		1%
Interest Rate	[3],[6]		10.19%
Acquisition Date	[3]		Sep. 01, 2021
Maturity Date	[3]		Sep. 01, 2026
Par Amount	[3]		$ 5,358
Cost	[3]		5,279
Fair Value	[3]		$ 5,358
AmeriMark Intermediate Holdings, LLC | Internet & Catalog Retail | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3],[7],[8],[9]	Internet & Catalog Retail
Spread above Index	[3],[4],[7],[8],[9]	S+800
Floor	[3],[7],[8],[9]	1%
Interest Rate	[3],[5],[7],[8],[9]	0%
Acquisition Date	[3],[7],[8],[9]	Jul. 28, 2021
Maturity Date	[3],[7],[8],[9]	Oct. 15, 2026
Par Amount	[3],[7],[8],[9]	$ 16,488
Cost	[3],[7],[8],[9]	15,017
Fair Value	[3],[7],[8],[9]	$ 4,516
AmeriMark Intermediate Holdings, LLC | Internet & Catalog Retail | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3],[10]		Internet & Catalog Retail
Spread above Index	[3],[4],[10]		L+800
Floor	[3],[10]		1%
Interest Rate	[3],[6],[10]		14.77%
Acquisition Date	[3],[10]		Jul. 28, 2021
Maturity Date	[3],[10]		Oct. 15, 2026
Par Amount	[3],[10]		$ 21,189
Cost	[3],[10]		20,858
Fair Value	[3],[10]		$ 20,129
AmeriMark Intermediate Holdings, LLC | Internet & Catalog Retail | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[7],[8]	Internet & Catalog Retail
Spread above Index	[4],[7],[8]	P+475
Floor	[7],[8]	1%
Interest Rate	[5],[7],[8]	13%
Acquisition Date	[7],[8]	Jun. 16, 2023
Maturity Date	[7],[8]	Aug. 04, 2023
Par Amount	[7],[8]	$ 408
Cost	[7],[8]	408
Fair Value	[7],[8]	$ 408
Apex Service Partners, LLC | Diversified Consumer Services | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Diversified Consumer Services
Spread above Index	[3],[4]	S+525
Floor	[3]	1%
Interest Rate	[3],[5]	10.55%
Acquisition Date	[3]	Nov. 05, 2021
Maturity Date	[3]	Jul. 31, 2025
Par Amount	[3]	$ 20,699
Cost	[3]	20,449
Fair Value	[3]	$ 20,699
Apex Service Partners, LLC | Diversified Consumer Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Diversified Consumer Services
Spread above Index	[3],[4]		S+525
Floor	[3]		1%
Interest Rate	[3],[6]		9.42%
Acquisition Date	[3]		Nov. 05, 2021
Maturity Date	[3]		Jul. 31, 2025
Par Amount	[3]		$ 21,450
Cost	[3]		21,134
Fair Value	[3]		$ 21,450
Arcutis Biotherapeutics, Inc. | Pharmaceuticals | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3],[11]	Pharmaceuticals
Spread above Index	[3],[4],[11]	L+745
Floor	[3],[11]	0.10%
Interest Rate	[3],[5],[11]	12.61%
Acquisition Date	[3],[11]	Dec. 22, 2021
Maturity Date	[3],[11]	Jan. 01, 2027
Par Amount	[3],[11]	$ 24,520
Cost	[3],[11]	24,847
Fair Value	[3],[11]	$ 24,827
Arcutis Biotherapeutics, Inc. | Pharmaceuticals | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3],[12]		Pharmaceuticals
Spread above Index	[3],[4],[12]		L+745
Floor	[3],[12]		0.10%
Interest Rate	[3],[6],[12]		11.62%
Acquisition Date	[3],[12]		Dec. 22, 2021
Maturity Date	[3],[12]		Jan. 01, 2027
Par Amount	[3],[12]		$ 24,520
Cost	[3],[12]		24,654
Fair Value	[3],[12]		$ 24,827
Ardelyx, Inc. | Pharmaceuticals | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3],[11]	Pharmaceuticals
Spread above Index	[3],[4],[11]	S+795
Floor	[3],[11]	1%
Interest Rate	[3],[5],[11]	13.15%
Acquisition Date	[3],[11]	Feb. 23, 2022
Maturity Date	[3],[11]	Mar. 01, 2027
Par Amount	[3],[11]	$ 3,319
Cost	[3],[11]	3,346
Fair Value	[3],[11]	$ 3,352
Ardelyx, Inc. | Pharmaceuticals | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3],[12]		Pharmaceuticals
Spread above Index	[3],[4],[12]		L+795
Floor	[3],[12]		0.10%
Interest Rate	[3],[6],[12]		12.12%
Acquisition Date	[3],[12]		Feb. 23, 2022
Maturity Date	[3],[12]		Mar. 01, 2027
Par Amount	[3],[12]		$ 3,319
Cost	[3],[12]		3,328
Fair Value	[3],[12]		$ 3,328
Basic Fun, Inc. | Specialty Retail | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Specialty Retail
Spread above Index	[3],[4]	S+650
Floor	[3]	1%
Interest Rate	[3],[5]	12.04%
Acquisition Date	[3]	Oct. 30, 2020
Maturity Date	[3]	Oct. 30, 2023
Par Amount	[3]	$ 960
Cost	[3]	959
Fair Value	[3]	$ 960
Basic Fun, Inc. | Specialty Retail | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Specialty Retail
Spread above Index	[3],[4]		L+550
Floor	[3]		1%
Interest Rate	[3],[6]		10.27%
Acquisition Date	[3]		Oct. 30, 2020
Maturity Date	[3]		Oct. 30, 2023
Par Amount	[3]		$ 966
Cost	[3]		961
Fair Value	[3]		$ 966
BayMark Health Services, Inc. | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Health Care Providers & Services
Spread above Index	[3],[4]	S+500
Floor	[3]	1%
Interest Rate	[3],[5]	10.50%
Acquisition Date	[3]	Jun. 29, 2021
Maturity Date	[3]	Jun. 11, 2027
Par Amount	[3]	$ 15,782
Cost	[3]	15,666
Fair Value	[3]	$ 15,782
BayMark Health Services, Inc. | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Health Care Providers & Services
Spread above Index	[3],[4]		L+500
Floor	[3]		1%
Interest Rate	[3],[6]		9.73%
Acquisition Date	[3]		Jun. 29, 2021
Maturity Date	[3]		Jun. 11, 2027
Par Amount	[3]		$ 15,861
Cost	[3]		15,733
Fair Value	[3]		$ 15,861
BridgeBio Pharma, Inc. | Biotechnology | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3],[11]	Biotechnology
Spread above Index	[3],[4],[11]	0
Floor	[3],[11]	0%
Interest Rate	[3],[5],[11],[13]	9%
Acquisition Date	[3],[11]	Nov. 17, 2021
Maturity Date	[3],[11]	Nov. 17, 2026
Par Amount	[3],[11]	$ 14,581
Cost	[3],[11]	14,523
Fair Value	[3],[11]	$ 14,581
BridgeBio Pharma, Inc. | Biotechnology | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3],[12]		Biotechnology
Spread above Index	[3],[4],[12]		0
Floor	[3],[12]		0%
Interest Rate	[3],[6],[12],[13]		9%
Acquisition Date	[3],[12]		Nov. 17, 2021
Maturity Date	[3],[12]		Nov. 17, 2026
Par Amount	[3],[12]		$ 14,362
Cost	[3],[12]		14,257
Fair Value	[3],[12]		$ 14,362
CC SAG Holdings Corp. (Spectrum Automotive) | Diversified Consumer Services | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Diversified Consumer Services
Spread above Index	[3],[4]	S+575
Floor	[3]	0.75%
Interest Rate	[3],[5]	11.25%
Acquisition Date	[3]	Jun. 29, 2021
Maturity Date	[3]	Jun. 29, 2028
Par Amount	[3]	$ 12,609
Cost	[3]	12,441
Fair Value	[3]	$ 12,609
CC SAG Holdings Corp. (Spectrum Automotive) | Diversified Consumer Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Diversified Consumer Services
Spread above Index	[3],[4]		L+575
Floor	[3]		0.75%
Interest Rate	[3],[6]		10.48%
Acquisition Date	[3]		Jun. 29, 2021
Maturity Date	[3]		Jun. 29, 2028
Par Amount	[3]		$ 6,491
Cost	[3]		6,407
Fair Value	[3]		$ 6,491
Centrexion Therapeutics, Inc. | Pharmaceuticals | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Pharmaceuticals
Spread above Index	[3],[4]	L+725
Floor	[3]	2.45%
Interest Rate	[3],[5]	12.41%
Acquisition Date	[3]	Jun. 28, 2019
Maturity Date	[3]	Jan. 01, 2024
Par Amount	[3]	$ 1,246
Cost	[3]	1,371
Fair Value	[3]	$ 1,401
Centrexion Therapeutics, Inc. | Pharmaceuticals | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry			Pharmaceuticals
Spread above Index	[4]		L+725
Floor			2.45%
Interest Rate	[6]		11.42%
Acquisition Date			Jun. 28, 2019
Maturity Date			Jan. 01, 2024
Par Amount			$ 2,314
Cost			2,417
Fair Value			$ 2,453
Cerapedics, Inc. | Biotechnology | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Biotechnology
Spread above Index	[3],[4]	S+620
Floor	[3]	2.75%
Interest Rate	[3],[5]	11.37%
Acquisition Date	[3]	Dec. 27, 2022
Maturity Date	[3]	Jan. 01, 2028
Par Amount	[3]	$ 9,698
Cost	[3]	9,704
Fair Value	[3]	$ 9,722
Cerapedics, Inc. | Biotechnology | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Biotechnology
Spread above Index	[3],[4]		S+620
Floor	[3]		2.75%
Interest Rate	[3],[6]		10.52%
Acquisition Date	[3]		Dec. 27, 2022
Maturity Date	[3]		Jan. 01, 2028
Par Amount	[3]		$ 9,698
Cost	[3]		9,674
Fair Value	[3]		$ 9,673
Enhanced Permanent Capital, LLC | Capital Markets | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3],[11]	Capital Markets
Spread above Index	[3],[4],[11]	S+700
Floor	[3],[11]	1%
Interest Rate	[3],[5],[11]	11.93%
Acquisition Date	[3],[11]	Dec. 29, 2020
Maturity Date	[3],[11]	Dec. 29, 2025
Par Amount	[3],[11]	$ 9,257
Cost	[3],[11]	9,083
Fair Value	[3],[11]	$ 9,257
Enhanced Permanent Capital, LLC | Capital Markets | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3],[12]		Capital Markets
Spread above Index	[3],[4],[12]		L+700
Floor	[3],[12]		1%
Interest Rate	[3],[6],[12]		10.13%
Acquisition Date	[3],[12]		Dec. 29, 2020
Maturity Date	[3],[12]		Dec. 29, 2025
Par Amount	[3],[12]		$ 7,503
Cost	[3],[12]		7,352
Fair Value	[3],[12]		$ 7,503
ENS Holdings III Corp. & ES Opco USA LLC (BlueFin) | Trading Companies & Distributors | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Trading Companies & Distributors
Spread above Index	[3],[4]	S+475
Floor	[3]	1%
Interest Rate	[3],[5]	10.09%
Acquisition Date	[3]	Dec. 31, 2019
Maturity Date	[3]	Dec. 31, 2025
Par Amount	[3]	$ 7,143
Cost	[3]	7,079
Fair Value	[3]	$ 7,143
ENS Holdings III Corp. & ES Opco USA LLC (BlueFin) | Trading Companies & Distributors | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Trading Companies & Distributors
Spread above Index	[3],[4]		S+475
Floor	[3]		1%
Interest Rate	[3],[6]		9.43%
Acquisition Date	[3]		Dec. 31, 2019
Maturity Date	[3]		Dec. 31, 2025
Par Amount	[3]		$ 7,570
Cost	[3]		7,490
Fair Value	[3]		$ 7,570
Enverus Holdings, Inc. (fka Drilling Info Holdings) | IT Services | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	IT Services
Spread above Index	[3],[4]	S+450
Floor	[3]	0%
Interest Rate	[3],[5]	9.70%
Acquisition Date	[3]	Jan. 31, 2020
Maturity Date	[3]	Jul. 30, 2025
Par Amount	[3]	$ 14,096
Cost	[3]	13,936
Fair Value	[3]	$ 14,096
Enverus Holdings, Inc. (fka Drilling Info Holdings) | IT Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		IT Services
Spread above Index	[3],[4]		L+450
Floor	[3]		0%
Interest Rate	[3],[6]		8.88%
Acquisition Date	[3]		Jan. 31, 2020
Maturity Date	[3]		Jul. 30, 2025
Par Amount	[3]		$ 14,454
Cost	[3]		14,252
Fair Value	[3]		$ 14,454
Erie Construction Mid-west, LLC | Building Products | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Building Products
Spread above Index	[3],[4]	S+475
Floor	[3]	1%
Interest Rate	[3],[5]	10.34%
Acquisition Date	[3]	Aug. 05, 2021
Maturity Date	[3]	Jul. 30, 2027
Par Amount	[3]	$ 11,089
Cost	[3]	10,949
Fair Value	[3]	$ 11,089
Erie Construction Mid-west, LLC | Building Products | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Building Products
Spread above Index	[3],[4]		S+475
Floor	[3]		1%
Interest Rate	[3],[6]		9.79%
Acquisition Date	[3]		Aug. 05, 2021
Maturity Date	[3]		Jul. 30, 2027
Par Amount	[3]		$ 11,381
Cost	[3]		11,222
Fair Value	[3]		$ 11,381
Fertility (ITC) Investment Holdco, LLC | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Health Care Providers & Services
Spread above Index	[3],[4]	S+650
Floor	[3]	1%
Interest Rate	[3],[5]	11.63%
Acquisition Date	[3]	Jan. 04, 2023
Maturity Date	[3]	Jan. 03, 2029
Par Amount	[3]	$ 10,330
Cost	[3]	10,038
Fair Value	[3]	$ 10,330
Foundation Consumer Brands, LLC | Personal Products | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Personal Products
Spread above Index	[3],[4]	S+625
Floor	[3]	1%
Interest Rate	[3],[5]	11.47%
Acquisition Date	[3]	Feb. 12, 2021
Maturity Date	[3]	Feb. 12, 2027
Par Amount	[3]	$ 11,876
Cost	[3]	11,680
Fair Value	[3]	$ 11,876
Foundation Consumer Brands, LLC | Personal Products | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Personal Products
Spread above Index	[3],[4]		L+550
Floor	[3]		1%
Interest Rate	[3],[6]		10.15%
Acquisition Date	[3]		Feb. 12, 2021
Maturity Date	[3]		Feb. 12, 2027
Par Amount	[3]		$ 12,288
Cost	[3]		12,063
Fair Value	[3]		$ 12,288
Glooko, Inc. | Health Care Technology | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Health Care Technology
Spread above Index	[3],[4]	L+790
Floor	[3]	0.10%
Interest Rate	[3],[5]	13.06%
Acquisition Date	[3]	Sep. 30, 2021
Maturity Date	[3]	Oct. 01, 2026
Par Amount	[3]	$ 2,831
Cost	[3]	2,850
Fair Value	[3]	$ 2,852
Glooko, Inc. | Health Care Technology | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Health Care Technology
Spread above Index	[3],[4]		L+790
Floor	[3]		0.10%
Interest Rate	[3],[6]		12.07%
Acquisition Date	[3]		Sep. 30, 2021
Maturity Date	[3]		Oct. 01, 2026
Par Amount	[3]		$ 2,831
Cost	[3]		2,838
Fair Value	[3]		$ 2,838
GSM Acquisition Corp. | Leisure Equipment & Products | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Leisure Equipment & Products
Spread above Index	[3],[4]	S+500
Floor	[3]	1%
Interest Rate	[3],[5]	10.50%
Acquisition Date	[3]	Apr. 20, 2021
Maturity Date	[3]	Nov. 16, 2026
Par Amount	[3]	$ 13,998
Cost	[3]	13,904
Fair Value	[3]	$ 13,858
GSM Acquisition Corp. | Leisure Equipment & Products | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Leisure Equipment & Products
Spread above Index	[3],[4]		S+500
Floor	[3]		1%
Interest Rate	[3],[6]		9.03%
Acquisition Date	[3]		Apr. 20, 2021
Maturity Date	[3]		Nov. 16, 2026
Par Amount	[3]		$ 14,069
Cost	[3]		13,961
Fair Value	[3]		$ 13,928
Higginbotham Insurance Agency, Inc. | Insurance | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Insurance
Spread above Index	[3],[4]	S+525
Floor	[3]	1%
Interest Rate	[3],[5]	10.45%
Acquisition Date	[3]	Nov. 25, 2020
Maturity Date	[3]	Nov. 25, 2026
Par Amount	[3]	$ 8,089
Cost	[3]	8,012
Fair Value	[3]	$ 8,089
Higginbotham Insurance Agency, Inc. | Insurance | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Insurance
Spread above Index	[3],[4]		L+525
Floor	[3]		0.75%
Interest Rate	[3],[6]		9.63%
Acquisition Date	[3]		Nov. 25, 2020
Maturity Date	[3]		Nov. 25, 2026
Par Amount	[3]		$ 8,130
Cost	[3]		8,043
Fair Value	[3]		$ 8,130
High Street Buyer, Inc. | Insurance | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Insurance
Spread above Index	[3],[4]	S+600
Floor	[3]	0.75%
Interest Rate	[3],[5]	10.79%
Acquisition Date	[3]	Apr. 16, 2021
Maturity Date	[3]	Apr. 16, 2028
Par Amount	[3]	$ 11,886
Cost	[3]	11,698
Fair Value	[3]	$ 11,886
High Street Buyer, Inc. | Insurance | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Insurance
Spread above Index	[3],[4]		L+600
Floor	[3]		0.75%
Interest Rate	[3],[6]		8.75%
Acquisition Date	[3]		Apr. 16, 2021
Maturity Date	[3]		Apr. 16, 2028
Par Amount	[3]		$ 11,606
Cost	[3]		11,408
Fair Value	[3]		$ 11,606
Human Interest Inc | Internet Software & Services | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Internet Software & Services
Spread above Index	[3],[4]	S+785
Floor	[3]	1%
Interest Rate	[3],[5]	13.01%
Acquisition Date	[3]	Jun. 30, 2022
Maturity Date	[3]	Jul. 01, 2027
Par Amount	[3]	$ 6,799
Cost	[3]	6,717
Fair Value	[3]	$ 6,799
Human Interest Inc | Internet Software & Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Internet Software & Services
Spread above Index	[3],[4]		S+785
Floor	[3]		1%
Interest Rate	[3],[6]		11.97%
Acquisition Date	[3]		Jun. 30, 2022
Maturity Date	[3]		Jul. 01, 2027
Par Amount	[3]		$ 6,799
Cost	[3]		6,690
Fair Value	[3]		$ 6,799
iCIMS, Inc. | Software | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Software
Spread above Index	[3],[4]	S+725
Floor	[3]	0.75%
Interest Rate	[3],[5],[14]	12.38%
Acquisition Date	[3]	Aug. 18, 2022
Maturity Date	[3]	Aug. 18, 2028
Par Amount	[3]	$ 13,974
Cost	[3]	13,759
Fair Value	[3]	$ 13,974
iCIMS, Inc. | Software | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Software
Spread above Index	[3],[4]		S+725
Floor	[3]		0.75%
Interest Rate	[3],[6],[14]		11.52%
Acquisition Date	[3]		Aug. 18, 2022
Maturity Date	[3]		Aug. 18, 2028
Par Amount	[3]		$ 13,757
Cost	[3]		13,527
Fair Value	[3]		$ 13,517
Ivy Fertility Services, LLC | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Health Care Providers & Services
Spread above Index	[3],[4]		L+625
Floor	[3]		1%
Interest Rate	[3],[6]		10.39%
Acquisition Date	[3]		Dec. 22, 2021
Maturity Date	[3]		Feb. 25, 2026
Par Amount	[3]		$ 10,515
Cost	[3]		10,369
Fair Value	[3]		$ 10,620
Kaseya, Inc. | Software | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Software
Spread above Index	[3],[4]	S+575
Floor	[3]	0.75%
Interest Rate	[3],[5],[15]	11.35%
Acquisition Date	[3]	Jun. 22, 2022
Maturity Date	[3]	Jun. 23, 2029
Par Amount	[3]	$ 11,006
Cost	[3]	10,860
Fair Value	[3]	$ 11,006
Kaseya, Inc. | Software | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Software
Spread above Index	[3],[4]		S+575
Floor	[3]		0.75%
Interest Rate	[3],[6]		10.33%
Acquisition Date	[3]		Jun. 22, 2022
Maturity Date	[3]		Jun. 23, 2029
Par Amount	[3]		$ 10,966
Cost	[3]		10,810
Fair Value	[3]		$ 10,966
Kid Distro Holdings, LLC (Distro Kid) | Software | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Software
Spread above Index	[3],[4]	S+575
Floor	[3]	1%
Interest Rate	[3],[5]	11.14%
Acquisition Date	[3]	Sep. 24, 2021
Maturity Date	[3]	Oct. 01, 2027
Par Amount	[3]	$ 12,394
Cost	[3]	12,207
Fair Value	[3]	$ 12,394
Kid Distro Holdings, LLC (Distro Kid) | Software | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Software
Spread above Index	[3],[4]		L+575
Floor	[3]		1%
Interest Rate	[3],[6]		10.48%
Acquisition Date	[3]		Sep. 24, 2021
Maturity Date	[3]		Oct. 01, 2027
Par Amount	[3]		$ 12,457
Cost	[3]		12,251
Fair Value	[3]		$ 12,457
KORE Wireless Group, Inc. | Wireless Telecommunication Services | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Wireless Telecommunication Services
Spread above Index	[3],[4]	S+550
Floor	[3]	0%
Interest Rate	[3],[5]	10.84%
Acquisition Date	[3]	Mar. 12, 2019
Maturity Date	[3]	Dec. 21, 2024
Par Amount	[3]	$ 14,030
Cost	[3]	13,945
Fair Value	[3]	$ 14,030
KORE Wireless Group, Inc. | Wireless Telecommunication Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Wireless Telecommunication Services
Spread above Index	[3],[4]		S+550
Floor	[3]		0%
Interest Rate	[3],[6]		10.08%
Acquisition Date	[3]		Mar. 12, 2019
Maturity Date	[3]		Dec. 21, 2024
Par Amount	[3]		$ 14,104
Cost	[3]		13,992
Fair Value	[3]		$ 14,104
Maurices, Incorporated | Specialty Retail | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Specialty Retail
Spread above Index	[3],[4]	S+675
Floor	[3]	1%
Interest Rate	[3],[5]	9.78%
Acquisition Date	[3]	Aug. 27, 2021
Maturity Date	[3]	Jun. 01, 2024
Par Amount	[3]	$ 5,286
Cost	[3]	5,265
Fair Value	[3]	$ 5,286
Maurices, Incorporated | Specialty Retail | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Specialty Retail
Spread above Index	[3],[4]		S+675
Floor	[3]		1%
Interest Rate	[3],[6]		8.74%
Acquisition Date	[3]		Aug. 27, 2021
Maturity Date	[3]		Jun. 01, 2024
Par Amount	[3]		$ 4,947
Cost	[3]		4,891
Fair Value	[3]		$ 4,947
Meditrina, Inc. | Health Care Equipment & Supplies | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Health Care Equipment & Supplies
Spread above Index	[3],[4]	S+550
Floor	[3]	3.45%
Interest Rate	[3],[5]	10.67%
Acquisition Date	[3]	Dec. 20, 2022
Maturity Date	[3]	Dec. 01, 2027
Par Amount	[3]	$ 1,212
Cost	[3]	1,208
Fair Value	[3]	$ 1,212
Meditrina, Inc. | Health Care Equipment & Supplies | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Health Care Equipment & Supplies
Spread above Index	[3],[4]		S+550
Floor	[3]		3.45%
Interest Rate	[3],[6]		9.82%
Acquisition Date	[3]		Dec. 20, 2022
Maturity Date	[3]		Dec. 01, 2027
Par Amount	[3]		$ 1,212
Cost	[3]		1,201
Fair Value	[3]		$ 1,209
MRI Software LLC | Software | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Software
Spread above Index	[3],[4]	S+550
Floor	[3]	1%
Interest Rate	[3],[5]	10.83%
Acquisition Date	[3]	Jul. 23, 2019
Maturity Date	[3]	Feb. 10, 2026
Par Amount	[3]	$ 15,230
Cost	[3]	15,120
Fair Value	[3]	$ 15,230
MRI Software LLC | Software | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Software
Spread above Index	[3],[4]		L+550
Floor	[3]		1%
Interest Rate	[3],[6]		10.23%
Acquisition Date	[3]		Jul. 23, 2019
Maturity Date	[3]		Feb. 10, 2026
Par Amount	[3]		$ 15,308
Cost	[3]		15,180
Fair Value	[3]		$ 15,308
NAC Holding Corporation (Jaguar) | Insurance | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Insurance
Spread above Index	[3],[4]		S+525
Floor	[3]		1%
Interest Rate	[3],[6]		9.45%
Acquisition Date	[3]		Jul. 30, 2021
Maturity Date	[3]		Sep. 28, 2024
Par Amount	[3]		$ 12,461
Cost	[3]		12,355
Fair Value	[3]		$ 12,461
Neuronetics, Inc. | Health Care Equipment & Supplies | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Health Care Equipment & Supplies
Spread above Index	[3],[4]	S+565
Floor	[3]	3.95%
Interest Rate	[3],[5]	10.82%
Acquisition Date	[3]	Mar. 02, 2020
Maturity Date	[3]	Mar. 29, 2028
Par Amount	[3]	$ 3,274
Cost	[3]	3,272
Fair Value	[3]	$ 3,282
Neuronetics, Inc. | Health Care Equipment & Supplies | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Health Care Equipment & Supplies
Spread above Index	[3],[4]		L+765
Floor	[3]		1.66%
Interest Rate	[3],[6]		11.82%
Acquisition Date	[3]		Mar. 02, 2020
Maturity Date	[3]		Feb. 28, 2025
Par Amount	[3]		$ 3,056
Cost	[3]		3,143
Fair Value	[3]		$ 3,224
Nexus Intermediate III, LLC (Vortex) | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Professional Services
Spread above Index	[3],[4]	L+550
Floor	[3]	0.75%
Interest Rate	[3],[5]	10.82%
Acquisition Date	[3]	Dec. 13, 2021
Maturity Date	[3]	Dec. 06, 2027
Par Amount	[3]	$ 5,411
Cost	[3]	5,338
Fair Value	[3]	$ 5,411
Nexus Intermediate III, LLC (Vortex) | Professional Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Professional Services
Spread above Index	[3],[4]		L+550
Floor	[3]		0.75%
Interest Rate	[3],[6]		10.22%
Acquisition Date	[3]		Dec. 13, 2021
Maturity Date	[3]		Dec. 06, 2027
Par Amount	[3]		$ 5,947
Cost	[3]		5,858
Fair Value	[3]		$ 5,947
Oral Surgery Partners Holdings, LLC | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Health Care Providers & Services
Spread above Index	[3],[4]		S+625
Floor	[3]		1%
Interest Rate	[3],[6]		10.92%
Acquisition Date	[3]		Nov. 29, 2022
Maturity Date	[3]		May 10, 2024
Par Amount	[3]		$ 2,206
Cost	[3]		2,164
Fair Value	[3]		$ 2,162
Orthopedic Care Partners Management, LLC | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Health Care Providers & Services
Spread above Index	[3],[4]	S+650
Floor	[3]	1%
Interest Rate	[3],[5]	11.66%
Acquisition Date	[3]	Aug. 17, 2022
Maturity Date	[3]	May 16, 2024
Par Amount	[3]	$ 5,672
Cost	[3]	5,646
Fair Value	[3]	$ 5,672
Orthopedic Care Partners Management, LLC | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Health Care Providers & Services
Spread above Index	[3],[4]		S+650
Floor	[3]		1%
Interest Rate	[3],[6]		10.91%
Acquisition Date	[3]		Aug. 17, 2022
Maturity Date	[3]		May 16, 2024
Par Amount	[3]		$ 4,226
Cost	[3]		4,200
Fair Value	[3]		$ 4,226
Outset Medical, Inc. | Health Care Equipment & Supplies | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3],[11]	Health Care Equipment & Supplies
Spread above Index	[3],[4],[11]	S+515
Floor	[3],[11]	2.75%
Interest Rate	[3],[5],[11]	10.32%
Acquisition Date	[3],[11]	Nov. 03, 2022
Maturity Date	[3],[11]	Nov. 01, 2027
Par Amount	[3],[11]	$ 11,865
Cost	[3],[11]	11,859
Fair Value	[3],[11]	$ 11,865
Outset Medical, Inc. | Health Care Equipment & Supplies | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3],[12]		Health Care Equipment & Supplies
Spread above Index	[3],[4],[12]		S+515
Floor	[3],[12]		2.75%
Interest Rate	[3],[6],[12]		9.33%
Acquisition Date	[3],[12]		Nov. 03, 2022
Maturity Date	[3],[12]		Nov. 01, 2027
Par Amount	[3],[12]		$ 11,865
Cost	[3],[12]		11,796
Fair Value	[3],[12]		$ 11,775
Pediatric Home Respiratory Services, LLC | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Health Care Providers & Services
Spread above Index	[3],[4]	S+625
Floor	[3]	1%
Interest Rate	[3],[5]	11.45%
Acquisition Date	[3]	Aug. 19, 2022
Maturity Date	[3]	Dec. 04, 2024
Par Amount	[3]	$ 2,685
Cost	[3]	2,653
Fair Value	[3]	$ 2,685
Pediatric Home Respiratory Services, LLC | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Health Care Providers & Services
Spread above Index	[3],[4]		S+625
Floor	[3]		1%
Interest Rate	[3],[6]		10.67%
Acquisition Date	[3]		Aug. 19, 2022
Maturity Date	[3]		Dec. 04, 2024
Par Amount	[3]		$ 1,802
Cost	[3]		1,778
Fair Value	[3]		$ 1,784
Peter C. Foy & Associates Insurance Services, LLC | Insurance | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Insurance
Spread above Index	[3],[4]	S+600
Floor	[3]	0.75%
Interest Rate	[3],[5]	11.22%
Acquisition Date	[3]	Oct. 29, 2021
Maturity Date	[3]	Nov. 01, 2028
Par Amount	[3]	$ 15,500
Cost	[3]	15,375
Fair Value	[3]	$ 15,500
Peter C. Foy & Associates Insurance Services, LLC | Insurance | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Insurance
Spread above Index	[3],[4]		S+600
Floor	[3]		0.75%
Interest Rate	[3],[6]		11.21%
Acquisition Date	[3]		Oct. 29, 2021
Maturity Date	[3]		Nov. 01, 2028
Par Amount	[3]		$ 15,579
Cost	[3]		15,444
Fair Value	[3]		$ 15,579
Pinnacle Treatment Centers, Inc. | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Health Care Providers & Services
Spread above Index	[3],[4]	S+675
Floor	[3]	1%
Interest Rate	[3],[5]	12.16%
Acquisition Date	[3]	Jan. 22, 2020
Maturity Date	[3]	Jan. 02, 2026
Par Amount	[3]	$ 8,297
Cost	[3]	8,208
Fair Value	[3]	$ 8,297
Pinnacle Treatment Centers, Inc. | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Health Care Providers & Services
Spread above Index	[3],[4]		S+650
Floor	[3]		1%
Interest Rate	[3],[6]		10.57%
Acquisition Date	[3]		Jan. 22, 2020
Maturity Date	[3]		Jan. 02, 2026
Par Amount	[3]		$ 8,339
Cost	[3]		8,233
Fair Value	[3]		$ 8,152
Plastics Management, LLC | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Health Care Providers & Services
Spread above Index	[3],[4]	S+500
Floor	[3]	1%
Interest Rate	[3],[5]	10.44%
Acquisition Date	[3]	Aug. 26, 2021
Maturity Date	[3]	Aug. 18, 2027
Par Amount	[3]	$ 15,135
Cost	[3]	14,971
Fair Value	[3]	$ 15,135
Plastics Management, LLC | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Health Care Providers & Services
Spread above Index	[3],[4]		S+500
Floor	[3]		1%
Interest Rate	[3],[6]		9.89%
Acquisition Date	[3]		Aug. 26, 2021
Maturity Date	[3]		Aug. 18, 2027
Par Amount	[3]		$ 12,117
Cost	[3]		11,967
Fair Value	[3]		$ 12,117
Revlon Consumer Products Corporation | Personal Products | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Personal Products
Spread above Index	[3],[4]		P+475
Floor	[3]		2.75%
Interest Rate	[3],[6]		12.25%
Acquisition Date	[3]		May 07, 2021
Maturity Date	[3]		Jun. 17, 2023
Par Amount	[3]		$ 13,905
Cost	[3]		13,876
Fair Value	[3]		$ 13,974
RQM+ Corp. | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Life Sciences Tools & Services
Spread above Index	[3],[4]	S+575
Floor	[3]	1%
Interest Rate	[3],[5]	11.51%
Acquisition Date	[3]	Aug. 20, 2021
Maturity Date	[3]	Aug. 12, 2026
Par Amount	[3]	$ 15,601
Cost	[3]	15,443
Fair Value	[3]	$ 15,601
RQM+ Corp. | Life Sciences Tools & Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Life Sciences Tools & Services
Spread above Index	[3],[4]		S+575
Floor	[3]		1%
Interest Rate	[3],[6]		10.59%
Acquisition Date	[3]		Aug. 20, 2021
Maturity Date	[3]		Aug. 12, 2026
Par Amount	[3]		$ 15,680
Cost	[3]		15,499
Fair Value	[3]		$ 15,680
RSC Acquisition, Inc. | Insurance | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Insurance
Spread above Index	[3],[4]	S+550
Floor	[3]	0.75%
Interest Rate	[3],[5]	10.64%
Acquisition Date	[3]	Oct. 05, 2020
Maturity Date	[3]	Nov. 01, 2026
Par Amount	[3]	$ 18,183
Cost	[3]	17,962
Fair Value	[3]	$ 18,183
RSC Acquisition, Inc. | Insurance | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Insurance
Spread above Index	[3],[4]		S+550
Floor	[3]		0.75%
Interest Rate	[3],[6]		9.26%
Acquisition Date	[3]		Oct. 05, 2020
Maturity Date	[3]		Nov. 01, 2026
Par Amount	[3]		$ 9,345
Cost	[3]		9,191
Fair Value	[3]		$ 9,345
RxSense Holdings LLC | Diversified Consumer Services | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Diversified Consumer Services
Spread above Index	[3],[4]	S+500
Floor	[3]	1%
Interest Rate	[3],[5]	10.15%
Acquisition Date	[3]	Mar. 17, 2020
Maturity Date	[3]	Mar. 13, 2026
Par Amount	[3]	$ 14,562
Cost	[3]	14,432
Fair Value	[3]	$ 14,562
RxSense Holdings LLC | Diversified Consumer Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Diversified Consumer Services
Spread above Index	[3],[4]		L+500
Floor	[3]		1%
Interest Rate	[3],[6]		9.41%
Acquisition Date	[3]		Mar. 17, 2020
Maturity Date	[3]		Mar. 13, 2026
Par Amount	[3]		$ 14,674
Cost	[3]		14,522
Fair Value	[3]		$ 14,674
Southern Orthodontic Partners Management, LLC | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Health Care Providers & Services
Spread above Index	[3],[4]	S+600
Floor	[3]	1%
Interest Rate	[3],[5]	11.50%
Acquisition Date	[3]	Jun. 03, 2022
Maturity Date	[3]	Jan. 27, 2026
Par Amount	[3]	$ 3,791
Cost	[3]	3,758
Fair Value	[3]	$ 3,791
Southern Orthodontic Partners Management, LLC | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Health Care Providers & Services
Spread above Index	[3],[4]		S+600
Floor	[3]		1%
Interest Rate	[3],[6]		10.84%
Acquisition Date	[3]		Jun. 03, 2022
Maturity Date	[3]		Jan. 27, 2026
Par Amount	[3]		$ 1,901
Cost	[3]		1,884
Fair Value	[3]		$ 1,901
Spectrum Pharmaceuticals, Inc. | Biotechnology | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Biotechnology
Spread above Index	[3],[4]	S+570
Floor	[3]	2.30%
Interest Rate	[3],[5]	10.87%
Acquisition Date	[3]	Sep. 21, 2022
Maturity Date	[3]	Sep. 01, 2027
Par Amount	[3]	$ 3,559
Cost	[3]	3,776
Fair Value	[3]	$ 3,835
Spectrum Pharmaceuticals, Inc. | Biotechnology | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Biotechnology
Spread above Index	[3],[4]		S+570
Floor	[3]		2.30%
Interest Rate	[3],[6]		9.88%
Acquisition Date	[3]		Sep. 21, 2022
Maturity Date	[3]		Sep. 01, 2027
Par Amount	[3]		$ 3,559
Cost	[3]		3,519
Fair Value	[3]		$ 3,524
SunMed Group Holdings, LLC | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Spread above Index	[3],[4]	S+575
Interest Rate	[3],[5]	11.09%
SunMed Group Holdings, LLC | Health Care Equipment & Supplies | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Health Care Equipment & Supplies
Floor	[3]	0.75%
Acquisition Date	[3]	Jun. 16, 2021
Maturity Date	[3]	Jun. 16, 2028
Par Amount	[3]	$ 7,643
Cost	[3]	7,542
Fair Value	[3]	$ 7,643
SunMed Group Holdings, LLC | Health Care Equipment & Supplies | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Health Care Equipment & Supplies
Spread above Index	[3],[4]		L+575
Floor	[3]		0.75%
Interest Rate	[3],[6]		10.48%
Acquisition Date	[3]		Jun. 16, 2021
Maturity Date	[3]		Jun. 16, 2028
Par Amount	[3]		$ 7,929
Cost	[3]		7,815
Fair Value	[3]		$ 7,929
TAUC Management, LLC | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Health Care Providers & Services
Spread above Index	[3],[4]	L+525
Floor	[3]	1%
Interest Rate	[3],[5]	10.59%
Acquisition Date	[3]	Feb. 12, 2021
Maturity Date	[3]	Feb. 12, 2027
Par Amount	[3]	$ 9,008
Cost	[3]	8,918
Fair Value	[3]	$ 8,557
TAUC Management, LLC | Health Care Providers & Services | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Health Care Providers & Services
Spread above Index	[3],[4]		L+525
Floor	[3]		1%
Interest Rate	[3],[6]		9.98%
Acquisition Date	[3]		Feb. 12, 2021
Maturity Date	[3]		Feb. 12, 2027
Par Amount	[3]		$ 9,013
Cost	[3]		8,912
Fair Value	[3]		$ 8,968
Tilley Distribution, Inc. | Trading Companies & Distributors | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Trading Companies & Distributors
Spread above Index	[3],[4]	S+600
Floor	[3]	1%
Interest Rate	[3],[5]	11.39%
Acquisition Date	[3]	Dec. 08, 2021
Maturity Date	[3]	Dec. 31, 2026
Par Amount	[3]	$ 12,557
Cost	[3]	12,443
Fair Value	[3]	$ 12,557
Tilley Distribution, Inc. | Trading Companies & Distributors | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Trading Companies & Distributors
Spread above Index	[3],[4]		S+550
Floor	[3]		1%
Interest Rate	[3],[6]		10.14%
Acquisition Date	[3]		Dec. 08, 2021
Maturity Date	[3]		Dec. 31, 2026
Par Amount	[3]		$ 12,762
Cost	[3]		12,633
Fair Value	[3]		$ 12,762
Transportation Insight, LLC | Road & Rail | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Road & Rail
Spread above Index	[3],[4]	S+450
Floor	[3]	1%
Interest Rate	[3],[5]	9.64%
Acquisition Date	[3]	Oct. 27, 2021
Maturity Date	[3]	Dec. 18, 2024
Par Amount	[3]	$ 5,581
Cost	[3]	5,528
Fair Value	[3]	$ 5,581
Transportation Insight, LLC | Road & Rail | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Road & Rail
Spread above Index	[3],[4]		L+450
Floor	[3]		1%
Interest Rate	[3],[6]		8.91%
Acquisition Date	[3]		Oct. 27, 2021
Maturity Date	[3]		Dec. 18, 2024
Par Amount	[3]		$ 4,198
Cost	[3]		4,150
Fair Value	[3]		$ 4,198
Ultimate Baked Goods Midco LLC (Rise Baking) | Packaged Foods & Meats | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Packaged Foods & Meats
Spread above Index	[3],[4]	S+625
Floor	[3]	1%
Interest Rate	[3],[5]	11.45%
Acquisition Date	[3]	Aug. 12, 2021
Maturity Date	[3]	Aug. 13, 2027
Par Amount	[3]	$ 7,593
Cost	[3]	7,454
Fair Value	[3]	$ 7,593
Ultimate Baked Goods Midco LLC (Rise Baking) | Packaged Foods & Meats | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Packaged Foods & Meats
Spread above Index	[3],[4]		L+650
Floor	[3]		1%
Interest Rate	[3],[6]		10.88%
Acquisition Date	[3]		Aug. 12, 2021
Maturity Date	[3]		Aug. 13, 2027
Par Amount	[3]		$ 7,877
Cost	[3]		7,717
Fair Value	[3]		$ 7,877
Vapotherm, Inc. | Health Care Equipment & Supplies | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Health Care Equipment & Supplies
Spread above Index	[3],[4]	S+930
Floor	[3]	1%
Interest Rate	[3],[5],[16]	14.57%
Acquisition Date	[3]	Feb. 18, 2022
Maturity Date	[3]	Feb. 01, 2027
Par Amount	[3]	$ 12,608
Cost	[3]	12,709
Fair Value	[3]	$ 12,766
Vapotherm, Inc. | Health Care Equipment & Supplies | Common Equity/Equity Interests/Warrants — 3.0%
Summary of Investment Holdings [Line Items]
Industry	[17]	Health Care Equipment & Supplies
Acquisition Date	[17]	Feb. 18, 2022
Par Amount	[17]	$ 72,556
Cost	[17]	93
Fair Value	[17]	$ 7
Vapotherm, Inc. | Health Care Equipment & Supplies | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Health Care Equipment & Supplies
Spread above Index	[3],[4]		S+830
Floor	[3]		1%
Interest Rate	[3],[6],[18]		12.58%
Acquisition Date	[3]		Feb. 18, 2022
Maturity Date	[3]		Feb. 01, 2027
Par Amount	[3]		$ 12,070
Cost	[3]		12,076
Fair Value	[3]		$ 12,131
Vapotherm, Inc. | Health Care Equipment & Supplies | Common Equity/Equity Interests/Warrants — 0.0%
Summary of Investment Holdings [Line Items]
Industry	[17]		Health Care Equipment & Supplies
Acquisition Date	[17]		Feb. 18, 2022
Par Amount	[17]		$ 12,960
Cost	[17]		75
Fair Value	[17]		$ 31
Vessco Midco Holdings, LLC | Water Utilities | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Water Utilities
Spread above Index	[3],[4]	S+450
Floor	[3]	1%
Interest Rate	[3],[5]	9.56%
Acquisition Date	[3]	Sep. 03, 2021
Maturity Date	[3]	Nov. 02, 2026
Par Amount	[3]	$ 3,742
Cost	[3]	3,711
Fair Value	[3]	$ 3,742
Vessco Midco Holdings, LLC | Water Utilities | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Water Utilities
Spread above Index	[3],[4]		L+450
Floor	[3]		1%
Interest Rate	[3],[6]		7.87%
Acquisition Date	[3]		Sep. 03, 2021
Maturity Date	[3]		Nov. 02, 2026
Par Amount	[3]		$ 2,207
Cost	[3]		2,189
Fair Value	[3]		$ 2,206
World Insurance Associates, LLC | Insurance | Bank Debt/Senior Secured Loans — 192.5%
Summary of Investment Holdings [Line Items]
Industry	[3]	Insurance
Spread above Index	[3],[4]	S+575
Floor	[3]	1%
Interest Rate	[3],[5]	10.99%
Acquisition Date	[3]	Oct. 12, 2020
Maturity Date	[3]	Apr. 01, 2026
Par Amount	[3]	$ 19,265
Cost	[3]	18,966
Fair Value	[3]	$ 19,265
World Insurance Associates, LLC | Insurance | Bank Debt/Senior Secured Loans — 271.5%
Summary of Investment Holdings [Line Items]
Industry	[3]		Insurance
Spread above Index	[3],[4]		S+575
Floor	[3]		1%
Interest Rate	[3],[6]		10.07%
Acquisition Date	[3]		Oct. 12, 2020
Maturity Date	[3]		Apr. 01, 2026
Par Amount	[3]		$ 19,614
Cost	[3]		19,261
Fair Value	[3]		$ 18,829
Centrexion Therapeutics, Inc. Warrants | Pharmaceuticals | Common Equity/Equity Interests/Warrants — 3.0%
Summary of Investment Holdings [Line Items]
Industry	[17]	Pharmaceuticals
Acquisition Date	[17]	Jun. 28, 2019
Par Amount	[17]	$ 56,483
Cost	[17]	27
Fair Value	[17]	$ 10
Centrexion Therapeutics, Inc. Warrants | Pharmaceuticals | Common Equity/Equity Interests/Warrants — 0.0%
Summary of Investment Holdings [Line Items]
Industry	[17]		Pharmaceuticals
Acquisition Date	[17]		Jun. 28, 2019
Par Amount	[17]		$ 56,483
Cost	[17]		27
Fair Value	[17]		$ 16
Meditrina, Inc. Warrants | Health Care Equipment & Supplies | Common Equity/Equity Interests/Warrants — 3.0%
Summary of Investment Holdings [Line Items]
Industry	[17]	Health Care Equipment & Supplies
Acquisition Date	[17]	Dec. 20, 2022
Par Amount	[17]	$ 10,572
Cost	[17]	8
Fair Value	[17]	$ 7
Meditrina, Inc. Warrants | Health Care Equipment & Supplies | Common Equity/Equity Interests/Warrants — 0.0%
Summary of Investment Holdings [Line Items]
Industry	[17]		Health Care Equipment & Supplies
Acquisition Date	[17]		Dec. 20, 2022
Par Amount	[17]		$ 10,572
Cost	[17]		8
Fair Value	[17]		$ 8
Senseonics Holdings, Inc. Common Stock | Health Care Equipment & Supplies | Common Equity/Equity Interests/Warrants — 3.0%
Summary of Investment Holdings [Line Items]
Industry	[11],[17]	Health Care Equipment & Supplies
Acquisition Date	[11],[17]	Jul. 25, 2019
Par Amount	[11],[17]	$ 79,501
Cost	[11],[17]	23
Fair Value	[11],[17]	$ 61
Senseonics Holdings, Inc. Common Stock | Health Care Equipment & Supplies | Common Equity/Equity Interests/Warrants — 0.0%
Summary of Investment Holdings [Line Items]
Industry	[12],[17]		Health Care Equipment & Supplies
Acquisition Date	[12],[17]		Jul. 25, 2019
Par Amount	[12],[17]		$ 79,501
Cost	[12],[17]		23
Fair Value	[12],[17]		$ 82
SLR-AMI Topco Blocker, LLC | Internet & Catalog Retail | Common Equity/Equity Interests/Warrants — 3.0%
Summary of Investment Holdings [Line Items]
Industry	[8],[17],[19]	Internet & Catalog Retail
Acquisition Date	[8],[17],[19]	Jun. 16, 2023
Par Amount	[8],[17],[19]	$ 0
Cost	[8],[17],[19]	6,170
Fair Value	[8],[17],[19]	$ 7,826
Spectrum Pharmaceuticals, Inc. Warrants | Biotechnology | Common Equity/Equity Interests/Warrants — 3.0%
Summary of Investment Holdings [Line Items]
Industry	[17]	Biotechnology
Acquisition Date	[17]	Sep. 21, 2022
Par Amount	[17]	$ 53,930
Cost	[17]	17
Fair Value	[17]	$ 27
Spectrum Pharmaceuticals, Inc. Warrants | Biotechnology | Common Equity/Equity Interests/Warrants — 0.0%
Summary of Investment Holdings [Line Items]
Industry	[17]		Biotechnology
Acquisition Date	[17]		Sep. 21, 2022
Par Amount	[17]		$ 53,930
Cost	[17]		17
Fair Value	[17]		$ 5
[1]Aggregate net unrealized depreciation for U.S. federal income tax purposes is $9,108; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $6,687 and $15,795, respectively, based on a tax cost of $531,577. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.[2]Aggregate net unrealized depreciation for U.S. federal income tax purposes is $927; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $5,202 and $6,129, respectively, based on a tax cost of $533,822. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.[3]Indicates an investment that is wholly or partially held by SCP Private Credit Income BDC LLC (the “Company”, “we”, “us” or “our”) through its wholly-owned financing subsidiary SCP Private Credit Income BDC SPV LLC (the “SPV”). Such investments are pledged as collateral under the SPV Facility (see Note 5 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.[4]Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.[5]Floating rate debt investments typically bear interest at a rate determined by reference to either the London Interbank Offered Rate (“LIBOR” or “L”) index rate, the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (PRIME or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of June 30, 2023.[6]Floating rate debt investments typically bear interest at a rate determined by reference to either the London Interbank Offered Rate (“LIBOR” or “L”) index rate, the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (PRIME or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.[7]AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers.[8]Denotes investments in which we are an “Affiliated Person” but not exercising a controlling influence, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment.[9]Investment is on non-accrual status.[10]AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Amerimark may elect to defer up to 8.00% of the coupon as PIK.[11]Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the Investment Company Act of 1940, as amended (the “1940 Act”). If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of June 30, 2023, on a fair value basis, non-qualifying assets in the portfolio represented 11.9% of the total assets of the Company.[12]Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the Investment Company Act of 1940, as amended (“1940 Act”). If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis, non-qualifying assets in the portfolio represented 11.2% of the total assets of the Company.[13]BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.[14]iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK.[15]Kaseya, Inc. may elect to defer up to 2.50% of the coupon as PIK.[16]Vapotherm, Inc. may elect to defer up to 9.00% of the coupon as PIK.[17]Non-income producing security.[18]Vapotherm, Inc. may elect to defer up to 8.00% of the coupon as PIK.[19]Through this entity and other intermediate entities, the Company owns approximately 6.5% of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former Amerimark Interactive, LLC.

Consolidated Schedule of Inve_2

Consolidated Schedule of Investments 1	Jun. 30, 2023	Dec. 31, 2022
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	100%	100%
Insurance
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	14%	14.30%
Health Care Providers & Services
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	13.40%	12.40%
Software
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	10.10%	9.80%
Diversified Consumer Services
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	9.20%	8%
Health Care Equipment & Supplies
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	7%	6.80%
Pharmaceuticals
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	6.80%	6.50%
Biotechnology
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	5.40%	5.20%
Trading Companies & Distributors
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	4.80%	4.80%
Life Sciences Tools & Services
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	3%	2.90%
IT Services
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	2.70%	2.70%
Wireless Telecommunication Services
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	2.70%	2.70%
Leisure Equipment & Products
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	2.60%	2.60%
Internet & Catalog Retail
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	2.40%	3.80%
Diversified Financial Services
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	2.40%	2.40%
Personal Products
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	2.30%	4.90%
Building Products
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	2.10%	2.10%
Capital Markets
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	1.80%	1.40%
Packaged Foods & Meats
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	1.50%	1.50%
Internet Software & Services
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	1.30%	1.30%
Specialty Retail
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	1.20%	1.10%
Road & Rail
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	1.10%	0.80%
Professional Services
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	1%	1.10%
Water Utilities
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	0.70%	0.40%
Health Care Technology
Summary of Investment Holdings [Line Items]
Percentage Of Total Investments At Fair Value	0.50%	0.50%

Consolidated Schedule of Inve_3

Consolidated Schedule of Investments (Parethetical) - USD ($) $ in Thousands	1 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2023	Dec. 31, 2022
Summary of Investment Holdings [Line Items]
Tax Basis Of Investments Unrealized Appreciation Depreciation Net	$ 9,108	$ 9,108	$ 927
Tax Basis Of Investments Gross Unrealized Appreciation	6,687	6,687	5,202
Tax Basis Of Investments Gross Unrealized Depreciation	15,795	15,795	6,129
Tax Basis Of Investments Cost For Income Tax Purposes	531,577	531,577	$ 533,822
Investment, Affiliated Issuer, Noncontrolled [Member]
Summary of Investment Holdings [Line Items]
Fair Value at June 16, 2023	14,413
Gross Additions	408
Gross Reductions	0
Realized Gain (Loss)	0
Change in Unrealized Gain (Loss)	(2,071)
Interest/ Dividend Income	0
Fair Value at June 30, 2023	$ 12,750	$ 12,750
iCIMS, Inc.
Summary of Investment Holdings [Line Items]
Rate of coupon as PIK		3.875%	3.875%
Vapotherm, Inc.
Summary of Investment Holdings [Line Items]
Rate of coupon as PIK		9%	8%
Kaseya Inc [Member]
Summary of Investment Holdings [Line Items]
Rate of coupon as PIK		2.50%
ASC Holdco, LLC
Summary of Investment Holdings [Line Items]
Investment company percentage of ownership	6.50%	6.50%
BridgeBio Pharma, Inc.
Summary of Investment Holdings [Line Items]
Rate of coupon as PIK		3%	3%
AmeriMark Interactive LLC
Summary of Investment Holdings [Line Items]
Rate of coupon as PIK			8%
AmeriMark Intermediate Holdings, LLC | Investment, Affiliated Issuer, Noncontrolled [Member]
Summary of Investment Holdings [Line Items]
Fair Value at June 16, 2023	$ 8,243
Gross Additions	0
Gross Reductions	0
Realized Gain (Loss)	0
Change in Unrealized Gain (Loss)	(3,727)
Interest/ Dividend Income	0
Fair Value at June 30, 2023	4,516	$ 4,516
AmeriMark Intermediate Holdings, LLC | Investment, Affiliated Issuer, Noncontrolled [Member]
Summary of Investment Holdings [Line Items]
Fair Value at June 16, 2023	0
Gross Additions	408
Gross Reductions	0
Realized Gain (Loss)	0
Change in Unrealized Gain (Loss)	0
Interest/ Dividend Income	0
Fair Value at June 30, 2023	408	408
SLR-AMI Topco Blocker, LLC | Investment, Affiliated Issuer, Noncontrolled [Member]
Summary of Investment Holdings [Line Items]
Fair Value at June 16, 2023	6,170
Gross Additions	0
Gross Reductions	0
Realized Gain (Loss)	0
Change in Unrealized Gain (Loss)	1,656
Interest/ Dividend Income	0
Fair Value at June 30, 2023	$ 7,826	$ 7,826

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ 8,961	$ 4,175	$ 5,972	$ 8,990

Insider Trading Arrangements

Insider Trading Arrangements	6 Months Ended
	Jun. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Organization

Organization	6 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	Note 1. Organization SCP Private Credit Income BDC LLC (the “Company”, “we”, “us” or “our”) is a Delaware limited liability company formed on May 18, 2018 On October 5, 2018 (the “Initial Closing Date”), the Company closed on $326,000 in capital commitments. On March 12, 2019, the sale and issuance of 2,800,000 units, at an aggregate purchase price of $28,000 ($10.00 per unit) occurred and the Company commenced operations. As of June 30, 2023, $261,500 of capital commitments were drawn and $64,500 were unfunded. The Company has implemented a corporate lending strategy focused on sourcing, underwriting and managing a diverse portfolio of private senior secured loans primarily to upper middle market companies (generally, aggregate non-traditional The offering period of the Company ended on April 5, 2019 (the “Offering Period”). The investment period of the Company ended on December 31, 2022. The term of the Company will be six years from the end of the Offering Period unless the Company is liquidated earlier as set forth in the Limited Liability Company Agreement of the Company (as amended, restated or otherwise modified from time to time, the “LLC Agreement”), but may be extended by the board of directors for up to two consecutive one year periods upon approval of the Company’s independent directors and the approval of unitholders of the Company (“Unitholders”), which approval will be obtained through a non-1940

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”), and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to current period presentation. Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form 10-Q S-X, In the opinion of management, all adjustments which are of a normal recurring nature considered necessary for the fair presentation of financial statements, have been included. The significant accounting policies consistently followed by the Company are: (a) Investment transactions are accounted for on the trade date; (b) In accordance with GAAP and the 1940 Act, the Company’s assets will generally be valued as follows: (i) securities or other instruments (other than as referred to in clauses (ii) and (iii) below) for which market quotes are readily available and deemed to represent fair value under GAAP will be valued based on quotes obtained from a quotation reporting system, market makers or pricing services (when deemed to represent fair value under GAAP). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation; (ii) exchange-traded options, futures and options on futures will be valued at the settlement price determined by the exchange or through the use of a model such as Black-Scholes; (iii) short-term investments with maturities of sixty (60) days or less generally will be valued at amortized cost; and (iv) securities, loans or other instruments for which market quotes are not readily available or reliable under GAAP will be valued as described below: a. the quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of SLR responsible for the Portfolio Investment; b. preliminary valuation conclusions are then documented and discussed with senior management of the Adviser; c. the audit committee of the Board of Directors ( the “Board”) reviews the preliminary valuations of the Adviser and third party valuation specialist, if any, and responds to the valuation recommendations to reflect any comments; and d. the Board discusses valuations and determines the fair value of each investment in the Company’s portfolio in good faith based on the input of the Adviser, the audit committee, and third party valuation specialist, if any, which may from time to time be engaged by the Board. The valuation principles set forth above may be modified from time to time without notice to Unitholders, in whole or in part, as determined by the Board in its sole discretion. The Board will also (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule 2a-5 2a-5. When an external event such as a purchase transaction, public offering or subsequent equity sale occurs, the Company will consider the pricing indicated by the external event to corroborate the valuation. Due to the inherent uncertainty of determining the fair value of investments that do not have a readily available market value, the fair value of the investments may differ significantly from the values that would have been used had a readily available market value existed for such investments, and the differences could be material. Investments are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC 820-10, ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy: Level 1 Level 2 Level 3 In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience. (c) Gains or losses on investments are calculated by using the specific identification method. (d) The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other non-recurring (e) The Company intends to comply with the applicable provisions of the Code pertaining to RICs (f) Book and tax basis differences relating to Unitholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP. (g) Distributions to Unitholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually. (h) In accordance with Regulation S-X Consolidation (i) The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against the U.S. dollar on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company. (j) In accordance with ASC 835-30, (k) The Company records expenses related to applicable equity offering costs as a charge to capital upon the sale of units, in accordance with ASC 946-20-25. (l) Investments that are expected to pay regularly scheduled interest in cash are generally placed on non-accrual non-accrual (m) The Company records expenses directly related to its organization as incurred. (n) The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents.

Agreements and Related Party Tr

Agreements and Related Party Transactions	6 Months Ended
	Jun. 30, 2023
Agreements And Related Party Transactions [Abstract]
Agreements and Related Party Transactions	Note 3. Agreements and Related Party Transactions The Company has entered into an investment management agreement with the Adviser (the “Investment Management Agreement”) pursuant to which it will pay management fees, administrative coordinator fees and incentive fees to the Adviser. The Company will pay the Adviser a fee for investment advisory and management services consisting of two components: a base management fee and an incentive fee. The Company will also pay the Adviser (in its capacity as Administrative Coordinator, defined herein) an administration fee for administrative and coordination services. The cost of the base management fee, the incentive fee, and the administration fee will be borne by the Unitholders. Management Fees and Administration Fees The Company will pay the Adviser a management fee (the “Management Fee”), calculated as of the close of business in New York, New York on the last day of each calendar quarter (each such date, the “Management Fee Calculation Date”), in an amount equal to 1.5% per annum of Invested Capital (defined as, as of any date, the sum of (i) capital contributions to the Company plus (ii) the total amount of credit drawn on subscription credit facilities), and payable quarterly in arrears after such Management Fee Calculation Date. Pursuant to the Investment Management Agreement, the Adviser has also been appointed to provide administrative and coordination services to the Company (in such capacity, the “Administrative Coordinator”). The Company will pay the Administrative Coordinator, a fee (the “Administration Fee”), calculated as of the close of business in New York, New York on the last day of each calendar quarter (the “Administration Fee Calculation Date”), in an amount equal to 0.08% per annum of the average Cost Basis (defined as the aggregate accreted and amortized cost of all Portfolio Investments on-going, non-investment-related Each of the Management Fee and the Administration Fee will be appropriately adjusted for any stub period. Such fees will be paid out of net current income and/or disposition proceeds or, to the extent such amounts are not available, from unfunded capital commitments that will be drawn down, or borrowings of the Company. In the event that the Adviser arranges for the Company to pay any portion of a placement fee to a placement agent, the amount of Management Fees Incentive Fee The Company will make distributions out of two categories: Current Proceeds and Disposition Proceeds (collectively referred to as “Investment Proceeds”). “Disposition Proceeds” means all amounts received by the Company upon the disposition of an investment, including full or partial repayments or amortization of principal (but excluding Current Proceeds). “Current Proceeds” means all proceeds from investments, including interest income, fee income, warrant gains, prepayment fees and exit fees, other than Disposition Proceeds. The Adviser will apportion each Unitholder’s pro rata share of Investment Proceeds between Disposition Proceeds and Current Proceeds. Amounts of Investment Proceeds apportioned to Unitholders will be divided between and distributed to Unitholders, on the one hand, and the Adviser, on the other hand, in the following amounts and order of priority: (i) Disposition Proceeds apportioned to Unitholders shall be divided between and distributed to Unitholders, on the one hand, and paid to the Adviser as an incentive fee (A) Return of Capital Contributions (B) Unitholder Preferred Return Preferred Return”); (C) Adviser Catch Up to 15% incentive fee (D) 85%/15% Shares incentive fee. (ii) Current Proceeds apportioned to Unitholders shall be divided between and distributed to Unitholders, on the one hand, and paid to the Adviser as an incentive fee (A) Unitholder Preferred Return (B) Adviser Catch Up to 15% incentive fee (C) 85%/15% Units incentive fee. In no event will the Adviser receive amounts attributable to Disposition Proceeds that, as of any distribution or payment date, exceeds 20% of cumulative realized capital gains net of all cumulative realized capital losses and unrealized capital depreciation. The Adviser has the right with respect to all Unitholders, upon approval of the Company’s independent directors, to waive or reduce the incentive fee to which it is entitled. The Adviser may also elect not to receive all or any portion of the incentive fee that would otherwise be distributed to it, and may cause any or all amounts subsequently available for distribution to the Unitholders to be distributed to the Adviser until it has received the same aggregate amount of incentive fees had it not previously waived receipt of incentive fees. The Adviser will be entitled to withhold from any distributions, in its discretion, any required tax withholdings. Amounts of taxes paid or withheld from amounts otherwise distributable to a Unitholder will be deemed distributed for purposes of the calculations above. Upon liquidation of the Company, the Adviser will be required to restore funds to the Company for distribution to the Unitholders if and to the extent that the Adviser has received cumulative incentive fees in excess of the incentive fees that would have been payable to the Adviser on an aggregate basis covering all transactions of the Company; provided, however, that in no event will the Adviser be required to contribute an aggregate amount in excess of 100% of the net amount distributed to the Adviser (net of taxes) on account of its incentive fees. In addition, the Adviser will apply an interim incentive fee adjustment at the end of each fiscal year so that, in the event of any over-distribution of incentive fee to the Adviser (measured with respect to each Unitholder using the fair value of the Company’s portfolio at the end of the applicable fiscal year as if the Company were to liquidate on such date), future distributions that would, absent such interim incentive fee adjustment, otherwise be distributed to the Adviser as an incentive fee, shall be distributed to such Unitholder until such over-distribution (net of taxes payable by the Adviser with respect to such incentive fee) has been eliminated. For the three and six months ended June 30, 2023, the Company incurred $1,078 and $2,136, respectively, in Management Fees, $105 and $210, respectively, in Administration Fees and $1,582 and $1,054, respectively, in incentive fees incentive fees. The aggregate amount of certain operating expenses relating to Unitholders investing directly in the Company will not exceed the Operating Expense Cap, calculated as follows: (A) if the Company has less than or equal to $400,000 in capital commitments, an amount equal to the sum of (x) the product of the capital commitments and 0.0025 and (y) $1,250, or (B) if the Company has greater than $400,000 in capital commitments, $2,250. Any amount in excess of the Operating Expense Cap for any fiscal year will be paid by the Adviser. For the avoidance of doubt, the Operating Expense Cap will not apply to any fees, costs, expenses and liabilities allocable to persons investing indirectly in the Company through any Unitholder. The Adviser or Administrative Coordinator and/or their affiliates has advanced organizational and offering expenses to the Company, which include organizational fees, costs, expenses and liabilities of the Company, including legal expenses, incurred in connection with the initial offering of Units and the formation and establishment of the Company (“Organizational Expenses”). The Adviser or Administrative Coordinator (or such affiliate) has been reimbursed by the Company for such advanced costs and expenses in an amount not to exceed $500. $308 of offering expenses were charged to capital and $84 of organizational costs were expensed in 2019.

Fair Value

Fair Value	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value	Note 4. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows: Level 1. Level 2. a) Quoted prices for similar assets or liabilities in active markets; b) Quoted prices for identical or similar assets or liabilities in non-active c) Pricing models whose inputs are observable for substantially the full term of the asset or liability; and d) Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability. Level 3. When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3). A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1. The following tables present the balances of assets measured at fair value on a recurring basis, as of June 30, 2023 and December 31, 2022: Fair Value Measurements As of June 30, 2023 Level 1 Level 2 Level 3 Total Assets: Bank Debt/Senior Secured Loans $ — $ — $ 514,531 $ 514,531 Common Equity/Equity Interests/Warrants 61 — 7,877 7,938 Total Investments $ 61 $ — $ 522,408 $ 522,469 While the Company has not made an election to apply the fair value option of accounting to any of its debt obligations, if the Company’s debt obligations were carried at fair value at June 30, 2023, the fair value of the SPV Facility and the Subscription Facility would be $236,500 and $26,800, respectively. Fair Value Measurements As of December 31, 2022 Level 1 Level 2 Level 3 Total Assets: Bank Debt/Senior Secured Loans $ — $ — $ 532,753 $ 532,753 Common Equity/Equity Interests/Warrants 82 — 60 142 Total Investments $ 82 $ — $ 532,813 $ 532,895 While the Company has not made an election to apply the fair value option of accounting to any of its debt obligations, if the Company’s debt obligations were carried at fair value at December 31, 2022, the fair value of the SPV Facility and the Subscription Facility would be $267,726 and $70,400, respectively. The following table provides a summary of the changes in fair value of Level 3 assets for the three and six months ended June 30, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at June 30, 2023: Bank Debt/Senior Common Equity/Equity Total Fair value, March 31, 2023 $ 524,025 $ 44 $ 524,069 Total gains or losses included in earnings: Net realized gain 6 — 6 Net change in unrealized gain 635 1,652 2,287 Purchase of investment securities 31,071 6,181 37,252 Proceeds from dispositions of investment securities (41,206 ) — (41,206 ) Transfers into Level 3 — — — Transfers out of Level 3 — — — Fair value, June 30, 2023 $ 514,531 $ 7,877 $ 522,408 Unrealized gains for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized gain $ 731 $ 1,652 $ 2,383 Bank Debt/Senior Common Equity/Equity Total Fair value, December 31, 2022 $ 532,753 $ 60 $ 532,813 Total gains or losses included in earnings: Net realized gain 6 — 6 Net change in unrealized gain (loss) (9,788 ) 1,629 (8,159 ) Purchase of investment securities 60,089 6,188 66,277 Proceeds from dispositions of investment securities (68,529 ) — (68,529 ) Transfers into Level 3 — — — Transfers out of Level 3 — — — Fair value, June 30, 2023 $ 514,531 $ 7,877 $ 522,408 Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized gain (loss) $ (9,563 ) $ 1,629 $ (7,934 ) The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022: Bank Debt/Senior Common Equity/Equity Total Fair value, December 31, 2021 $ 439,661 $ 13 $ 439,674 Total gains or losses included in earnings: Net realized gain (loss) — — — Net change in unrealized gain (loss) 340 (53 ) 287 Purchase of investment securities 188,107 100 188,207 Proceeds from dispositions of investment securities (95,355 ) — (95,355 ) Transfers into Level 3 — — — Transfers out of Level 3 — — — Fair value, December 31, 2022 $ 532,753 $ 60 $ 532,813 Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized gain (loss) $ 744 $ (53 ) $ 691 Quantitative Information about Level 3 Fair Value Measurements The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company. Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities. Quantitative information about the Company’s Level 3 asset fair value measurements as of June 30, 2023 is summarized in the table below: Asset or Fair Value at Principal Valuation Unobservable Range (Weighted Senior Secured Loans Asset $ 510,015 Income Approach Market Yield 9.9% – 20.8% (12.0%) $ 4,516 Recovery Analysis Recoverable Amount N/A Common Equity/Equity Interests/Warrants Asset $ 51 Market Approach Volatility 17.3% - 17.3% (17.3%) $ 7,826 EBITDA Multiple Comparable Multiple 6.25x-7.25x (6.75x) Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving bid-ask Quantitative information about the Company’s Level 3 asset fair value measurements as of December 31, 2022 is summarized in the table below: Asset or Fair Value at Principal Valuation Unobservable Range (Weighted Senior Secured Loans Asset $ 532,753 Income Approach Market Yield 9.4% – 16.2% (11.4%) Common Equity/Equity Interests/Warrants Asset $ 60 Market Approach Volatility 26.0% - 26.0% (26.0%) Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving bid-ask

Debt

Debt	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Debt	Note 5. Debt SPV Facility Subscription Facility The average annualized interest cost for borrowings for the six months ended June 30, 2023 and the year ended December 31, 2022 was 7.93% and 4.67%, respectively. These costs are exclusive of other credit facility expenses such as unused fees and fees paid to the back-up

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 6. Commitments and Contingencies The Company had unfunded debt commitments to various revolving and delayed-draw term loans. The total amount of these unfunded commitments as of June 30, 2023 and December 31, 2022 is $59,616 and $98,214, respectively, comprised of the following: June 30, December 31, Outset Medical, Inc. $ 11,865 $ 11,865 Human Interest Inc. 6,799 6,799 Vessco Midco Holdings, LLC 3,417 4,969 Glooko, Inc. 3,185 3,185 Arcutis Biotherapeutics, Inc. 3,065 3,065 Ardelyx, Inc. 2,716 2,716 iCIMS, Inc. 2,665 3,867 Cerapedics, Inc. 2,424 2,424 High Street Buyer, Inc. 2,040 2,797 RxSense Holdings, LLC 1,558 1,558 Pediatric Home Respiratory Services, LLC 1,557 2,451 Enverus Holdings, Inc. 1,537 1,251 Maurices, Incorporated 1,491 2,733 RSC Acquisition, Inc. 1,419 10,328 Nexus Intermediate III, LLC (Vortex) 1,264 1,264 Meditrina, Inc. 1,212 1,212 Spectrum Pharmaceuticals, Inc. 1,186 2,966 Kid Distro Holdings, LLC 1,121 1,121 GSM Acquisition Corp. 1,101 1,101 Foundation Consumer Brands, LLC 967 967 Basic Fun, Inc. 960 1,195 Ultimate Baked Goods Midco LLC 750 578 Orthopedic Care Partners Management, LLC 729 2,200 Southern Orthodontic Partners Management, LLC 705 2,605 Kaseya, Inc. 625 1,315 MRI Software LLC 577 577 ENS Holdings III Corp. & ES Opco USA LLC 574 179 SunMed Group Holdings, LLC 515 268 Transportation Insight, LLC 454 1,860 World Insurance Associates, LLC 385 135 TAUC Management, LLC 385 385 Amerimark Intermediate Holdings, LLC 194 — CC SAG Holdings Corp. (Spectrum Automotive) 174 6,568 Oral Surgery Partners Holdings, LLC — 3,277 Plastics Management, LLC — 3,095 Erie Construction Mid-west, — 1,593 Tilley Chemical Buyer, Inc. — 670 Peter C. Foy & Associates Insurance Services, LLC — 570 Pinnacle Treatment Centers, Inc. — 520 Ivy Fertility Services, LLC — 499 BayMark Health Services, Inc. — 499 NAC Holdings Corporation — 470 Apex Service Partners, LLC — 345 All States Ag Parts, LLC — 172 Total Commitments $ 59,616 $ 98,214 The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of June 30, 2023 and December 31, 2022, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment. In the normal course of its business, we invest or trade in various financial instruments and may enter into various investment activities with off-balance off-balance

Unitholders' Capital

Unitholders' Capital	6 Months Ended
	Jun. 30, 2023
Limited Liability Company (LLC) Members' Equity [Abstract]
Unitholders' Capital	Note 7. Unitholders’ Capital Transactions in Unitholders’ capital were as follows: Three months Three months Units at beginning of period 25,190,253 17,137,275 Units issued — 1,855,288 Units issued and outstanding at end of period 25,190,253 18,992,563 Six months Six months Units at beginning of period 18,992,563 17,137,275 Units issued 6,197,690 1,855,288 Units issued and outstanding at end of period 25,190,253 18,992,563

Financial Highlights

Financial Highlights	6 Months Ended
	Jun. 30, 2023
Investment Company, Financial Highlights [Abstract]
Financial Highlights	Note 8. Financial Highlights The following is a schedule of financial highlights for the six months ended June 30, 2023 and June 30, 2022: Six months ended Six months ended Per Share Data: (a) Net asset value per unit, beginning of period $ 10.33 $ 10.28 Net investment income 0.60 0.49 Net realized and unrealized gain (loss) (0.32 )* 0.03 Net increase in Unitholders’ capital resulting from operations 0.28 0.52 Distributions to Unitholders: From distributable earnings — — Net asset value per unit, end of period $ 10.61 $ 10.80 Total Return (b)(c) 2.71 % 5.06 % Unitholders’ capital, end of period $ 267,226 $ 205,103 Units outstanding, end of period 25,190,253 18,992,563 Ratios to average net assets of Unitholders’ Capital (c): Net investment income 5.82 % 4.69 % Operating expenses 1.62 % 2.20 % Interest and other credit facility expenses 5.00 % 3.21 % Total expenses 6.62 % 5.41 % Average debt outstanding $ 285,613 $ 280,590 Portfolio turnover ratio 12.1 % 7.4 % (a) Calculated using the average units outstanding method. Weighted average units outstanding for the six months ended June 30, 2023 and June 30, 2022 were 23,512,651 and 17,342,279, respectively. (b) Calculated as the change in NAV per unit during the period plus distributions declared per unit, divided by the beginning NAV per unit. Total return does not include a sales load. (c) Not annualized for periods less than one year. * Includes the impact of the different unit amounts used in calculating per unit data as a result of calculating certain per unit data based upon the weighted average units outstanding during the period and certain per unit data based on the units outstanding as of a period end.

Subsequent Events

Subsequent Events	6 Months Ended
	Jun. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 9. Subsequent Events The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued. There have been no subsequent events that require recognition or disclosure in these consolidated financial statements.

Fair Value (Tables)

Fair Value (Tables)	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Summary of assets measured at fair value on a recurring basis	The following tables present the balances of assets measured at fair value on a recurring basis, as of June 30, 2023 and December 31, 2022: Fair Value Measurements As of June 30, 2023 Level 1 Level 2 Level 3 Total Assets: Bank Debt/Senior Secured Loans $ — $ — $ 514,531 $ 514,531 Common Equity/Equity Interests/Warrants 61 — 7,877 7,938 Total Investments $ 61 $ — $ 522,408 $ 522,469 While the Company has not made an election to apply the fair value option of accounting to any of its debt obligations, if the Company’s debt obligations were carried at fair value at June 30, 2023, the fair value of the SPV Facility and the Subscription Facility would be $236,500 and $26,800, respectively. Fair Value Measurements As of December 31, 2022 Level 1 Level 2 Level 3 Total Assets: Bank Debt/Senior Secured Loans $ — $ — $ 532,753 $ 532,753 Common Equity/Equity Interests/Warrants 82 — 60 142 Total Investments $ 82 $ — $ 532,813 $ 532,895
Summary of the changes in fair value of level 3 assets	The following table provides a summary of the changes in fair value of Level 3 assets for the three and six months ended June 30, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at June 30, 2023: Bank Debt/Senior Common Equity/Equity Total Fair value, March 31, 2023 $ 524,025 $ 44 $ 524,069 Total gains or losses included in earnings: Net realized gain 6 — 6 Net change in unrealized gain 635 1,652 2,287 Purchase of investment securities 31,071 6,181 37,252 Proceeds from dispositions of investment securities (41,206 ) — (41,206 ) Transfers into Level 3 — — — Transfers out of Level 3 — — — Fair value, June 30, 2023 $ 514,531 $ 7,877 $ 522,408 Unrealized gains for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized gain $ 731 $ 1,652 $ 2,383 Bank Debt/Senior Common Equity/Equity Total Fair value, December 31, 2022 $ 532,753 $ 60 $ 532,813 Total gains or losses included in earnings: Net realized gain 6 — 6 Net change in unrealized gain (loss) (9,788 ) 1,629 (8,159 ) Purchase of investment securities 60,089 6,188 66,277 Proceeds from dispositions of investment securities (68,529 ) — (68,529 ) Transfers into Level 3 — — — Transfers out of Level 3 — — — Fair value, June 30, 2023 $ 514,531 $ 7,877 $ 522,408 Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized gain (loss) $ (9,563 ) $ 1,629 $ (7,934 ) The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022: Bank Debt/Senior Common Equity/Equity Total Fair value, December 31, 2021 $ 439,661 $ 13 $ 439,674 Total gains or losses included in earnings: Net realized gain (loss) — — — Net change in unrealized gain (loss) 340 (53 ) 287 Purchase of investment securities 188,107 100 188,207 Proceeds from dispositions of investment securities (95,355 ) — (95,355 ) Transfers into Level 3 — — — Transfers out of Level 3 — — — Fair value, December 31, 2022 $ 532,753 $ 60 $ 532,813 Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period: Net change in unrealized gain (loss) $ 744 $ (53 ) $ 691
Summary of quantitative information about the company's level 3 asset fair value measurements	Quantitative information about the Company’s Level 3 asset fair value measurements as of June 30, 2023 is summarized in the table below: Asset or Fair Value at Principal Valuation Unobservable Range (Weighted Senior Secured Loans Asset $ 510,015 Income Approach Market Yield 9.9% – 20.8% (12.0%) $ 4,516 Recovery Analysis Recoverable Amount N/A Common Equity/Equity Interests/Warrants Asset $ 51 Market Approach Volatility 17.3% - 17.3% (17.3%) $ 7,826 EBITDA Multiple Comparable Multiple 6.25x-7.25x (6.75x) Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving bid-ask Quantitative information about the Company’s Level 3 asset fair value measurements as of December 31, 2022 is summarized in the table below: Asset or Fair Value at Principal Valuation Unobservable Range (Weighted Senior Secured Loans Asset $ 532,753 Income Approach Market Yield 9.4% – 16.2% (11.4%) Common Equity/Equity Interests/Warrants Asset $ 60 Market Approach Volatility 26.0% - 26.0% (26.0%)

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Summary of unfunded commitments	The Company had unfunded debt commitments to various revolving and delayed-draw term loans. The total amount of these unfunded commitments as of June 30, 2023 and December 31, 2022 is $59,616 and $98,214, respectively, comprised of the following: June 30, December 31, Outset Medical, Inc. $ 11,865 $ 11,865 Human Interest Inc. 6,799 6,799 Vessco Midco Holdings, LLC 3,417 4,969 Glooko, Inc. 3,185 3,185 Arcutis Biotherapeutics, Inc. 3,065 3,065 Ardelyx, Inc. 2,716 2,716 iCIMS, Inc. 2,665 3,867 Cerapedics, Inc. 2,424 2,424 High Street Buyer, Inc. 2,040 2,797 RxSense Holdings, LLC 1,558 1,558 Pediatric Home Respiratory Services, LLC 1,557 2,451 Enverus Holdings, Inc. 1,537 1,251 Maurices, Incorporated 1,491 2,733 RSC Acquisition, Inc. 1,419 10,328 Nexus Intermediate III, LLC (Vortex) 1,264 1,264 Meditrina, Inc. 1,212 1,212 Spectrum Pharmaceuticals, Inc. 1,186 2,966 Kid Distro Holdings, LLC 1,121 1,121 GSM Acquisition Corp. 1,101 1,101 Foundation Consumer Brands, LLC 967 967 Basic Fun, Inc. 960 1,195 Ultimate Baked Goods Midco LLC 750 578 Orthopedic Care Partners Management, LLC 729 2,200 Southern Orthodontic Partners Management, LLC 705 2,605 Kaseya, Inc. 625 1,315 MRI Software LLC 577 577 ENS Holdings III Corp. & ES Opco USA LLC 574 179 SunMed Group Holdings, LLC 515 268 Transportation Insight, LLC 454 1,860 World Insurance Associates, LLC 385 135 TAUC Management, LLC 385 385 Amerimark Intermediate Holdings, LLC 194 — CC SAG Holdings Corp. (Spectrum Automotive) 174 6,568 Oral Surgery Partners Holdings, LLC — 3,277 Plastics Management, LLC — 3,095 Erie Construction Mid-west, — 1,593 Tilley Chemical Buyer, Inc. — 670 Peter C. Foy & Associates Insurance Services, LLC — 570 Pinnacle Treatment Centers, Inc. — 520 Ivy Fertility Services, LLC — 499 BayMark Health Services, Inc. — 499 NAC Holdings Corporation — 470 Apex Service Partners, LLC — 345 All States Ag Parts, LLC — 172 Total Commitments $ 59,616 $ 98,214

Unitholders' Capital (Tables)

Unitholders' Capital (Tables)	6 Months Ended
	Jun. 30, 2023
Limited Liability Company (LLC) Members' Equity [Abstract]
Summary of limited liability company unit holders capital	Transactions in Unitholders’ capital were as follows: Three months Three months Units at beginning of period 25,190,253 17,137,275 Units issued — 1,855,288 Units issued and outstanding at end of period 25,190,253 18,992,563 Six months Six months Units at beginning of period 18,992,563 17,137,275 Units issued 6,197,690 1,855,288 Units issued and outstanding at end of period 25,190,253 18,992,563

Financial Highlights (Tables)

Financial Highlights (Tables)	6 Months Ended
	Jun. 30, 2023
Investment Company, Financial Highlights [Abstract]
Summary of investment company, financial highlights	The following is a schedule of financial highlights for the six months ended June 30, 2023 and June 30, 2022: Six months ended Six months ended Per Share Data: (a) Net asset value per unit, beginning of period $ 10.33 $ 10.28 Net investment income 0.60 0.49 Net realized and unrealized gain (loss) (0.32 )* 0.03 Net increase in Unitholders’ capital resulting from operations 0.28 0.52 Distributions to Unitholders: From distributable earnings — — Net asset value per unit, end of period $ 10.61 $ 10.80 Total Return (b)(c) 2.71 % 5.06 % Unitholders’ capital, end of period $ 267,226 $ 205,103 Units outstanding, end of period 25,190,253 18,992,563 Ratios to average net assets of Unitholders’ Capital (c): Net investment income 5.82 % 4.69 % Operating expenses 1.62 % 2.20 % Interest and other credit facility expenses 5.00 % 3.21 % Total expenses 6.62 % 5.41 % Average debt outstanding $ 285,613 $ 280,590 Portfolio turnover ratio 12.1 % 7.4 % (a) Calculated using the average units outstanding method. Weighted average units outstanding for the six months ended June 30, 2023 and June 30, 2022 were 23,512,651 and 17,342,279, respectively. (b) Calculated as the change in NAV per unit during the period plus distributions declared per unit, divided by the beginning NAV per unit. Total return does not include a sales load. (c) Not annualized for periods less than one year. * Includes the impact of the different unit amounts used in calculating per unit data as a result of calculating certain per unit data based upon the weighted average units outstanding during the period and certain per unit data based on the units outstanding as of a period end.

Organization - Additional Infor

Organization - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands			6 Months Ended
	Mar. 12, 2019	Oct. 05, 2018	Jun. 30, 2023
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Investment company committed capital		$ 326,000
Stock issued during period shares new issues	2,800,000
Stock issued during period value new issues	$ 28,000
Share price	$ 10
Investment company funded capital commitments			$ 261,500
Investment company unfunded capital commitments			64,500
Minimum [Member] | Investments [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Investee maximum borrowings			100,000
Earnings before interest tax depreciation and amortization			25,000
Maximum [Member] | Investments [Member]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Investee maximum borrowings			300,000
Earnings before interest tax depreciation and amortization			$ 100,000

Summary of Significant Accoun_2

Summary of Significant Accounting Policies - Additional Information (Detail)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Percentage of excise tax	4%

Agreements and Related Party _2

Agreements and Related Party Transactions - Additional Information (Detail) - USD ($) $ in Thousands			3 Months Ended		6 Months Ended
		Oct. 05, 2018	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Agreements And Related Party Transactions [Line Items]
Investment company, total return	[1],[2]				2.71%	5.06%
Percentage of reimbursement of distributions by adviser upon liquidation			100%		100%
Management fee expense			$ 1,078	$ 889	$ 2,136	$ 1,760
Administrative fees expense			105	93	210	181
Incentive fee expense			$ 1,582	736	$ 1,054	1,586
Investment company committed capital		$ 326,000
First, Unitholder Preferred Return [Member]
Agreements And Related Party Transactions [Line Items]
percentage of current proceeds to unitholders					100%
Second., Adviser Catch Up [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of total amount distributed to unitholders and advisers					15%
Percentage of Current Proceeds to Advisers					80%
Third Order of Priority Return of Capital Contributions [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of distribution to unitholders					85%
Percentage of distribution to adviser as an incentive fee					15%
Capital Commitment Condition One [Member]
Agreements And Related Party Transactions [Line Items]
Investment company committed capital					$ 400,000
Multiplier to capital commitment			0.0025		0.0025
Aggregate operating expenses relating to unitholders			$ 1,250		$ 1,250
Capital Commitment Condition Two [Member]
Agreements And Related Party Transactions [Line Items]
Investment company committed capital					400,000
Aggregate operating expenses relating to unitholders			2,250		$ 2,250
First Return Of Capital Contributions [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of disposition proceeds to unitholders					100%
Second Unitholder Preferred Return [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of disposition proceeds to unitholders					100%
Third Adviser Catch Up [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of disposition proceeds to advisers					80%
Percentage of total amount distributed to unitholders and advisers					15%
Fourth Order Of Priority Return Of Capital Contributions [Member]
Agreements And Related Party Transactions [Line Items]
Percentage of distribution to unitholders					85%
Percentage of distribution to adviser as an incentive fee					15%
Minimum [Member] | Second Unitholder Preferred Return [Member]
Agreements And Related Party Transactions [Line Items]
Investment company, total return					6%
Advisor [Member]
Agreements And Related Party Transactions [Line Items]
Management fee expense			1,078	889	$ 2,136	1,760
Administrative fees expense			105	93	210	181
Incentive fee expense			1,582	$ 736	1,054	$ 1,586
Reimbursement of organizational and offering expenses			500		500
Reimbursement of offering expenses			308		308
Reimbursement of organizational expenses			$ 84		$ 84
Management Fee [Member] | Advisor [Member]
Agreements And Related Party Transactions [Line Items]
Related party transaction rate					1.50%
Percentage of payment to placement agent					100%
Administration Fee [Member] | Advisor [Member]
Agreements And Related Party Transactions [Line Items]
Related party transaction rate					0.08%
[1]Calculated as the change in NAV per unit during the period plus distributions declared per unit, divided by the beginning NAV per unit. Total return does not include a sales load.[2]Not annualized for periods less than one year.

Fair Value - Summary of Assets

Fair Value - Summary of Assets Measured At Fair Value On A Recurring Basis (Detail) - Fair Value, Recurring [Member] - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	$ 522,469	$ 532,895
Bank Debt/Senior Secured Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	514,531	532,753
Common Equity/Equity Interests/Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	7,938	142
Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	61	82
Fair Value, Inputs, Level 1 [Member] | Bank Debt/Senior Secured Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 1 [Member] | Common Equity/Equity Interests/Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	61	82
Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 2 [Member] | Bank Debt/Senior Secured Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 2 [Member] | Common Equity/Equity Interests/Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	0	0
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	522,408	532,813
Fair Value, Inputs, Level 3 [Member] | Bank Debt/Senior Secured Loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	514,531	532,753
Fair Value, Inputs, Level 3 [Member] | Common Equity/Equity Interests/Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure	$ 7,877	$ 60

Fair Value - Summary of The Cha

Fair Value - Summary of The Changes In Fair Value Of Level 3 Assets (Detail) - Fair Value, Inputs, Level 3 [Member] - USD ($) $ in Thousands	3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Jun. 30, 2023	Dec. 31, 2022
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening balance	$ 524,069	$ 532,813	$ 439,674
Net realized gain (loss)	6	6	0
Net change in unrealized gain (loss)	2,287	(8,159)	287
Purchase of investment securities	37,252	66,277	188,207
Proceeds from dispositions of investment securities	(41,206)	(68,529)	(95,355)
Transfers into Level 3	0	0	0
Transfers out of Level 3	0	0	0
Closing balance	522,408	522,408	532,813
Net change in unrealized gain (loss)	2,383	(7,934)	691
Bank Debt/Senior Secured Loans
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening balance	524,025	532,753	439,661
Net realized gain (loss)	6	6	0
Net change in unrealized gain (loss)	635	(9,788)	340
Purchase of investment securities	31,071	60,089	188,107
Proceeds from dispositions of investment securities	(41,206)	(68,529)	(95,355)
Transfers into Level 3	0	0	0
Transfers out of Level 3	0	0	0
Closing balance	514,531	514,531	532,753
Net change in unrealized gain (loss)	731	(9,563)	744
Common Equity/Equity Interests/Warrants
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Opening balance	44	60	13
Net realized gain (loss)	0	0	0
Net change in unrealized gain (loss)	1,652	1,629	(53)
Purchase of investment securities	6,181	6,188	100
Proceeds from dispositions of investment securities	0	0	0
Transfers into Level 3	0	0	0
Transfers out of Level 3	0	0	0
Closing balance	7,877	7,877	60
Net change in unrealized gain (loss)	$ 1,652	$ 1,629	$ (53)

Fair Value - Summary of Quantit

Fair Value - Summary of Quantitative Information About The Company's Level 3 Asset Fair Value Measurements (Detail) - Fair Value, Inputs, Level 3 [Member] $ in Thousands	Jun. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Bank Debt/Senior Secured Loans | Valuation Technique Recovery Analysis Model [Member] | Measurement Input Recoverable Amount [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, Fair Value Disclosure	$ 4,516
Senior Secured Loans [Member] | Valuation, Income Approach [Member] | Measurement Input Market Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, Fair Value Disclosure	510,015	$ 532,753
Common Equity/Equity Interests/Warrants | Valuation, Market Approach [Member] | Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, Fair Value Disclosure	51	$ 60
Common Equity/Equity Interests/Warrants | Measurement Input, EBITDA Multiple [Member] | Measurement Input Comparable Multiple [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investments, Fair Value Disclosure	$ 7,826
Minimum [Member] | Senior Secured Loans [Member] | Valuation, Income Approach [Member] | Measurement Input Market Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	9.9	9.4
Minimum [Member] | Common Equity/Equity Interests/Warrants | Valuation, Market Approach [Member] | Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	17.3	26
Minimum [Member] | Common Equity/Equity Interests/Warrants | Measurement Input, EBITDA Multiple [Member] | Measurement Input Comparable Multiple [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	6.25
Maximum [Member] | Senior Secured Loans [Member] | Valuation, Income Approach [Member] | Measurement Input Market Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	20.8	16.2
Maximum [Member] | Common Equity/Equity Interests/Warrants | Valuation, Market Approach [Member] | Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	17.3	26
Maximum [Member] | Common Equity/Equity Interests/Warrants | Measurement Input, EBITDA Multiple [Member] | Measurement Input Comparable Multiple [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	7.25
Weighted Average [Member] | Senior Secured Loans [Member] | Valuation, Income Approach [Member] | Measurement Input Market Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	12	11.4
Weighted Average [Member] | Common Equity/Equity Interests/Warrants | Valuation, Market Approach [Member] | Measurement Input, Price Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	17.3	26
Weighted Average [Member] | Common Equity/Equity Interests/Warrants | Measurement Input, EBITDA Multiple [Member] | Measurement Input Comparable Multiple [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Alternative Investment, Measurement Input	6.75

Fair Value - Additional informa

Fair Value - Additional information (Detail) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
SPV Facility [Member]
Line of Credit Facility [Line Items]
Line of credit facility, Fair value of amount outstanding	$ 236,500	$ 267,726
Subscription Facility [Member]
Line of Credit Facility [Line Items]
Line of credit facility, Fair value of amount outstanding	$ 26,800	$ 70,400

Debt - Additional Information (

Debt - Additional Information (Detail) - USD ($) $ in Thousands

3 Months Ended

6 Months Ended

12 Months Ended

Dec. 28, 2022

Aug. 18, 2021

Mar. 31, 2019

Mar. 31, 2019

Jun. 30, 2023

Dec. 31, 2022

Aug. 03, 2022

Nov. 02, 2021

Oct. 04, 2021

Jul. 16, 2021

Mar. 05, 2021

Feb. 27, 2021

Nov. 18, 2019

Jun. 24, 2019

Line of Credit Facility [Line Items]

Line Of Credit Facility Maximum Borrowing Capacity

$ 35,000

$ 35,000

Long term debt weighted average interest over a period of time

7.93%

4.67%

Line of credit facility, average outstanding amount

$ 338,126

$ 343,350

Subscription Facility [Member]

Line of Credit Facility [Line Items]

Long-Term Line of Credit

26,685

70,215

SPV Facility [Member]

Line of Credit Facility [Line Items]

Line Of Credit Facility Maximum Borrowing Capacity

$ 200,000

$ 300,000

$ 275,000

$ 125,000

$ 100,000

$ 75,000

Long-Term Line of Credit

235,800

$ 266,334

Minimum [Member] | SPV Facility [Member]

Line of Credit Facility [Line Items]

Line Of Credit Facility Maximum Borrowing Capacity

100,000

100,000

Maximum [Member] | SPV Facility [Member]

Line of Credit Facility [Line Items]

Line Of Credit Facility Maximum Borrowing Capacity

400,000

400,000

East West Bank [Member] | Subscription Facility [Member]

Line of Credit Facility [Line Items]

Line Of Credit Facility Maximum Borrowing Capacity

$ 75,000

$ 35,000

$ 35,000

$ 100,000

$ 75,000

$ 50,000

Long-Term Line of Credit

26,800

Line of credit facility, expiration date

Dec. 31, 2023

London Interbank Offered Rate (LIBOR) [Member] | SPV Facility [Member]

Line of Credit Facility [Line Items]

Debt Instrument, Basis Spread on Variable Rate

2.90%

Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member] | East West Bank [Member] | Subscription Facility [Member]

Line of Credit Facility [Line Items]

Debt Instrument, Basis Spread on Variable Rate

2.80%

JPMorgan Chase Bank [Member] | SCP Private Credit Income BDC SPV LLC [Member] | SPV Facility [Member]

Line of Credit Facility [Line Items]

Line of Credit Facility, Unused Capacity, Commitment Fee Percentage

0.875%

Long-Term Line of Credit

$ 236,500

Line of credit facility, expiration date

Dec. 31, 2023

Dec. 31, 2023

Commitments and Contingencies -

Commitments and Contingencies - Summary of Unfunded Commitments (Detail) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	$ 59,616	$ 98,214
Outset Medical, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	11,865	11,865
Human Interest Inc
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	6,799	6,799
Vessco Midco Holdings, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	3,417	4,969
Glooko, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	3,185	3,185
Arcutis Biotherapeutics, Inc
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	3,065	3,065
Ardelyx, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	2,716	2,716
iCIMS, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	2,665	3,867
High Street Buyer, Inc
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	2,040	2,797
RxSense Holdings LLC.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,558	1,558
Pediatric Home Respiratory Services, LLC.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,557	2,451
Peter C. Foy & Associates Insurance Services, LLC..
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	570
RSC Acquisition, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,419	10,328
CC SAG Holdings Corp. (Spectrum Automotive)..
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	174	6,568
Oral Surgery Partners Holdings, LLC.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	3,277
Southern Orthodontic Partners Management, LLC.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	705	2,605
Maurices, Incorporated
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,491	2,733
Spectrum Pharmaceuticals, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,186	2,966
Plastics Management, LLC.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	3,095
Transportation Insight, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	454	1,860
Cerapedics, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	2,424	2,424
Orthopedic Care Partners Management, LLC.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	729	2,200
NAC Holdings Corporation
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	470
Enverus Holdings, Inc. (fka Drilling Info Holdings)
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,537	1,251
Erie Construction Mid-west, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	1,593
Ivy Fertility Services, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	499
Kaseya, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	625	1,315
Nexus Intermediate III, LLC (Vortex)
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,264	1,264
ENS Holdings III Corp. & ES Opco USA LLC (BlueFin)
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	574	179
All States Ag Parts, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	172
Kid Distro Holdings, LLC (Distro Kid)
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,121	1,121
Meditrina, Inc.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,212	1,212
Basic Fun, Inc. ..
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	960	1,195
Foundation Consumer Brands, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	967	967
Apex Service Partners, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	345
GSM Acquisition Corp
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	1,101	1,101
BayMark Health Services, Inc
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	499
MRI Software LLC.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	577	577
Tilley Chemical Buyer, Inc
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	0	670
AmeriMark Intermediate Holdings, LLC [Member]
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	194	0
TAUC Management, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	385	385
Ultimate Baked Goods Midco LLC (Rise Baking)
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	750	578
SunMed Group Holdings, LLC
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	515	268
World Insurance Associates, LLC.
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	385	135
Pinnacle Treatment Centers, Inc. ..
Schedule Of Unfunded Commitments [Line Items]
Unfunded commitments	$ 0	$ 520

Commitments and Contingencies_2

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Unfunded commitments	$ 59,616	$ 98,214
Revolving Term Loans [Member]
Unfunded commitments	$ 59,616	$ 98,214

Unitholders' Capital - Summary

Unitholders' Capital - Summary of Limited Liability Company Unit Holders Capital (Detail) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Schedule Of Members Equity [Line Items]
Units at beginning of period	25,190,253	17,137,275	18,992,563	17,137,275
Units issued	0	1,855,288	6,197,690	1,855,288
Units issued and outstanding at end of period	25,190,253	18,992,563	25,190,253	18,992,563

Financial Highlights - Summary

Financial Highlights - Summary of Investment Company, Financial Highlights (Detail) - USD ($) $ / shares in Units, $ in Thousands		6 Months Ended
		Jun. 30, 2023		Jun. 30, 2022
Per Share Data:
Net asset value per unit, beginning of period		$ 10.33		$ 10.28
Net investment income		0.6		0.49
Net realized and unrealized gain (loss)		(0.32)	[1]	0.03
Net increase in Unitholders' capital resulting from operations		0.28		0.52
Distributions to Unitholders:
From distributable earnings		0		0
Net asset value per unit, end of period		$ 10.61		$ 10.8
Total Return	[2],[3]	2.71%		5.06%
Unitholders' capital, end of period		$ 267,226		$ 205,103
Units issued and outstanding at end of period		25,190,253		18,992,563
Ratios to average net assets of Unitholders' Capital:
Net investment income	[3]	5.82%		4.69%
Operating expenses	[3]	1.62%		2.20%
Interest and other credit facility expenses	[3]	5%		3.21%
Total expenses	[3]	6.62%		5.41%
Average debt outstanding	[3]	$ 285,613		$ 280,590
Portfolio turnover ratio	[3]	12.10%		7.40%
[1]Includes the impact of the different unit amounts used in calculating per unit data as a result of calculating certain per unit data based upon the weighted average units outstanding during the period and certain per unit data based on the units outstanding as of a period end.[2]Calculated as the change in NAV per unit during the period plus distributions declared per unit, divided by the beginning NAV per unit. Total return does not include a sales load.[3]Not annualized for periods less than one year.

Financial Highlights - Summar_2

Financial Highlights - Summary of Investment Company, Financial Highlights (Parenthetical) (Detail) - shares	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Weighted average limited liability company units outstanding	23,512,651	17,342,279